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Daniel Abebe Asfaw 
AVOIDING BAD CONTROL IN REGRESSION FOR PARTIALLY QUALITATIVE 
OUTCOMES, AND CORRECTING FOR ENDOGENEITY BIAS IN TWO-PART 
MODELS: CAUSAL INFERENCE FROM THE POTENTIAL OUTCOMES 
PERSPECTIVE 
 The general potential outcomes framework (GPOF) is an essential structure that 
facilitates clear and coherent specification, identification, and estimation of causal effects. 
This dissertation utilizes and extends the GPOF, to specify, identify, and estimate causally 
interpretable (CI) effect parameter (EP) for an outcome of interest that manifests as either 
a value in a specified subset of the real line or a qualitative event -- a partially qualitative 
outcome (PQO). The limitations of the conventional GPOF for casting a regression model 
for a PQO is discussed. The GPOF is only capable of delivering an EP that is subject to a 
bias due to bad control. The dissertation proposes an outcome measure that maintains all 
of the essential features of a PQO that is entirely real-valued and is not subject to the bad 
control critique; the P-weighted outcome – the outcome weighted by the probability that it 
manifests as a quantitative (real) value. I detail a regression-based estimation method for 
such EP and, using simulated data, demonstrate its implementation and validate its 
consistency for the targeted EP. The practicality of the proposed approach is demonstrated 
by estimating the causal effect of a fully effective policy that bans pregnant women from 
smoking during pregnancy on a new measure of birth weight. The dissertation also 
proposes a Generalized Control Function (GCF) approach for modeling and estimating a 
CI parameter in the context of a fully parametric two-part model (2PM) for a continuous 
outcome in which the causal variable of interest is continuous and endogenous. The 
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proposed approach is cast within the GPOF. Given a fully parametric specification for the 
causal variable and under regular Instrumental Variables (IV) assumptions, the approach 
is shown to satisfy the conditional independence assumption that is often difficult to hold 
under alternative approaches. Using simulated data, a full information maximum likelihood 
(FIML) estimator is derived for estimating the “deep” parameters of the model. The 
Average Incremental Effect (AIE) estimator based on these deep parameter estimates is 
shown to outperform other conventional estimators. I apply the method for estimating the 
medical care cost of obesity in youth in the US. 
         
        Joseph V. Terza, Ph.D., Chair 
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Chapter 1  
Introduction, Background and Significance, Summary 
 Causal Inference is at the heart of nearly all empirical economic research. Essential 
for conducting valid causal inference are rigorous specification and accurate estimation of 
parameters that characterize causal relationships of interest. In this dissertation, two 
regression-based approaches are developed. The first one is designed for specification and 
estimation of causally interpretable (CI) parameter for Partially Qualitative Outcomes 
(PQO) ‒ outcomes that manifest either as a value on the real line or as a qualitative event. 
Birth weight is an example of a PQO because it is observed only when a pregnancy ends 
in a live birth; otherwise, the outcome would be non-live birth. The second approach is 
developed for specification, identification, and estimation of CI parameters in Two-Part 
Model (2PM) context for continuous nonnegative outcomes where the causal variable of 
interest is continuous and endogenous. To ensure causal interpretability of the targeted 
parameters and their estimates, both approaches are developed within the General Potential 
Outcomes framework (GPOF).  
 In the conventional Conditional Potential Outcomes Model (CPOM), an essential 
model within the GPOF, outcomes are assumed to manifest either exclusively as a value on 
the real line or exclusively as a qualitative event. Casting a regression model for a PQO 
using the CPOM is difficult because to satisfy the aforementioned assumption, one needs 
to ignore either the quantitative or the qualitative component of the PQO. While focusing 
only on the qualitative component will change the causal inference objective, ignoring it 
would cause a bias due to bad control. The dissertation proposes an outcome measure that 
maintains all of the essential features of a PQO that is entirely real-valued and is not subject 
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to the bad control critique; the P-weighted outcome – the outcome weighted by the 
probability that it manifests as a quantitative (real) value. A regression-based estimation 
method for such effect parameters is detailed and using simulated data, I demonstrate its 
implementation and validate its consistency for the targeted effect parameter. To 
demonstrate the practicality of the proposed approach, I apply the model and method to 
estimate the causal effect of a fully effective policy that bans pregnant women from 
smoking during pregnancy on a new measure of birth weight. 
 The 2PM is one of the most widely applied empirical modeling and estimation 
framework in empirical health economics. In this dissertation, I extend the generic fully 
parametric 2PM (FP2PM) framework developed in Hao and Terza (2018) to accommodate 
cases in which the causal variable of interest is endogenous. The proposed approach 
considers continuous outcome and continuous endogenous variable. By casting the 
parameter of interest within the GPOF, the proposed approach provides a consistent 
definition of endogeneity. In particular, I propose a generalized control function (GCF) 
approach to identify, estimate and draw inference for an average incremental effect (AIE) 
of a one-unit change in the causal variable of interest. Under regular Instrumental Variables 
(IV) assumptions, the GCF is shown to satisfy the conditional independence assumption 
that is often difficult to hold in alternative approaches. Within a FP2PM framework, the 
GCF specification implies a full information maximum likelihood (FIML) model whose 
parameters are estimated by FIML method. I call this estimator for the “deep” parameters 
the Generalized Control Function-Full Information Maximum Likelihood (GCF-FIML) 
estimator. The GCF-FIML is able to identify causal effects that vary across units in the 
population based on unobservable characteristics. Using these “deep” parameters, the AIE 
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(the main object of interest) is specified and estimated. The GCF estimator within the 
FP2PM allows to test two important null hypotheses: “no 2PM is needed” and “the causal 
variable is exogenous”. In a simulation study, the proposed GCF-FIML based estimator for 
the targeted parameter is shown to outperform conventional estimators that are used in 
empirical research. Finally, using data from the Medical Expenditure Panel Survey, the 
model and method are illustrated by estimating the causal effect of a unit increase in Body 
Mass Index (BMI) and of moving an average obese individual to an average normal weight 
BMI on health care cost in youth in the US. A comparison of the result based on the 
proposed GCF approach to the two-stage predictor substitution estimator used in Biener et 
al (2020) reveals that the latter significantly overestimates the effect of a change in 
BMI/obesity on medical care cost. 
  The remaining part of the dissertation is organized as follows. In chapter 2, 
specification, identification, and estimation of CI parameter within the GPOF is discussed. 
I start by specifying an AIE based on relevant counterfactuals. Then a regression model is 
detailed that can be used to estimate the AIE using observable (factual) data from an 
appropriately specified Data Generating Process (DGP). The conditions under which such 
substitution is legitimate is also detailed. This discussion is extended to define endogeneity 
of the causal variable of interest and mention a general point on how to correct a bias caused 
by endogeneity. In the last section, an important implicit assumption within the GPOF is 
discussed that limits its applicability to a special kind of outcomes. This limitation is then 
addressed in chapter 3 in the context of a PQO. By presenting a detailed overview of the 
GPOF, chapter 2 lays the ground for the approaches developed in chapters 3 and 4.  
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 Chapter 3 begins by providing definition of a PQO and further elaborating the 
limitation of the conventional GPOF. Then, a new outcome measure is defined by 
extending the GPOF that is capable of casting a regression model that maintains all the 
essential features of a PQO and enables estimation of CI parameter. I present the extended 
GPOF along with the corresponding regression modeling and estimation method. Then, a 
simulation study is presented that demonstrates the implementation of the proposed 
regression model and validate its consistency for estimating the specified AIE. This is 
followed by an empirical application of the proposed approach.  
 In chapter 4, I first specify an AIE in the context of a FP2PM for a continuous 
outcome in which the causal variable of interest is continuous and endogenous. Then, the 
proposed identification approach is detailed and a FIML model is presented followed by a 
discussion on estimation of the “deep” parameters of the model. A section is devoted to 
present statistical tests for two important null hypotheses. A simulation study follows in 
which the implementation of the proposed GCF-FIML estimator is demonstrated and its 
consistency for estimating an AIE is evaluated. Therein, the performance of the GCF-FIML 
estimator is compared with alternative approaches. Then an empirical application is 
presented where I demonstrate the implementation of the proposed approach and compare 
the estimated AIE to those obtained by using alternative estimators. Chapter 5 summarizes 







Causal Inference Within and Outside the Conventional General Potential Outcomes 
Framework 
 Assessing causal relationships of interest based on relevant counterfactuals is at the 
heart of nearly all empirical economic research. Essential to such assessments are rigorous 
specification and accurate estimation of parameters that describe the relationship between 
a presumed causal variable of interest, X, whose value is to be set and altered in the context 
of relevant counterfactual, and a designated outcome of interest, Y.1 Relationships of this 
type are typically characterized by an effect parameter (EP) and estimation of the EP is the 
objective of the empirical analysis. The general potential outcomes framework (GPOF) 
provides a means to coherently define the EP in such a way that it is causally interpretable 
(CI).2 
 This chapter presents the GPOF in the context of estimating an average incremental 
effect (AIE) as an example of an EP that is considered in many empirical contexts. Within 
the GPOF, I detail specification of the AIE based on a conditional mean function implied 
by a conditional probability density function (pdf) for the Y given an exogenously set 
values of the X. Then, the conditional potential outcomes model (CPOM) – a model that 
facilitates a regression-based approach for estimation of the EP within the GPOF ‒ is 
discussed. Therein, I also outline the conditions under which the stated EP can be identified 
 
1 Henceforth, X and Y are to be taken as global replacements for the phrases “presumed 
causal variable of interest” and “outcome of interest,” respectively. 
 
2 The GPOF is an extension of the potential outcomes framework of Rubin (1974) to non-
binary X and nonlinear Y.  
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and is estimable by using an observable version of the data. This will be followed by a 
discussion on a consistent definition of endogeneity within the GPOF that will be employed 
in chapter 4 where a regression-based modeling and an estimation approach is proposed to 
correcting endogeneity in 2PM. The chapter closes by discussing an implicit assumption 
in the GPOF about the way the Y manifests that, if not satisfied, requires an extension of 
the framework to casting a regression-based approach for estimating CI parameter. This 
point is further elaborated in chapter 3 where I discuss regression for PQO. 
2.1 The GPOF: Introduction, Basic Concepts and Definitions 
 Many existing empirical studies in health economics and health service research 
commence their discussion of a causal inference problem from the data generating process 
(DGP) from which sample values are drawn. By focusing only on the DGP, the 
conventional approach fails to explicitly incorporate relevant counterfactuals. This in turn 
renders the approach to be deficient in recognizing the conditions under which EPs are 
identified and estimation results are CI (Terza, 2019a).  
 Casting a causal inference problem exclusively based on the DGP is even more 
problematic when the specific empirical context involves endogeneity. This is because the 
conventional DGP-based approach defines endogeneity in ambiguous and self-obviating 
way (Terza, 2019b). The GPOF, on the other hand, provides a framework that facilitates a 
clear and rigorous definition of the EP based on relevant counterfactuals. It also enables 
the analyst to define endogeneity in sustainable and unambiguous way that delivers the 
analyst a path on which to expand the DGP by adding appropriate structure to achieve 
identification of CI parameters.  
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 In chapter 3, a special case is discussed where the conventional GPOF is limited 
for casting a regression model for an empirical context. In particular, I argue that for 
partially qualitative outcomes (PQO) – outcomes that manifest either as a value in a 
specified set of the real line or a qualitative event – it is not possible to define an EP that is 
real-valued and can be estimated without bias. The GPOF, however, can be extended by 
replying on its fundamental principle, viz. characterizing outcomes based on relevant 
counterfactuals. To set the stage for the proposed approach for PQO in chapter 3 and for 
correcting endogeneity in the context of 2PM in chapter 4, below I review the GPOF as 
detailed in Terza (2019a, 2019b). 
 Here the fundamental definitions and concepts that characterize the GPOF as 
detailed in Terza (2019a) is presented. I begin with definitions of the counterfactual and 
observable versions of the X and the Y. In the GPOF, two versions of the X are 
distinguished as: 
 X* ≡  the random variable representing the hypothetical (counterfactual) 
 exogenously mandated version of the distribution of the X that might result from a 
 policy intervention (X* is, by design, independent of all other variates germane to 
 specification, identification, and estimation of the EP of interest). 
and 
 X ≡  the random variable representing the observable (factual) version of the 
 distribution of the X (sampled values of the X are drawn from the distribution of 




Likewise, two versions of the Y are distinguished as:  
 Y
X*
≡ the random variable representing the distribution of the potential outcome, 
 defined as the counterfactual distribution of values of the Y that would have 
 manifested for a particular X*. 
and 
 Y ≡ the random variable representing the factual version of the distribution of the 
 Y (the sampled values of the outcome are drawn from the distribution of Y). 
Note that although X* is a random variable, its character is different from X, Y and Y
X*
. 
X* is a random variable in the sense that its value differs for each elementary unit in the 
population. Unlike X, Y and Y
X*
, the values of X* is determinate and knowable in the 
context of relevant counterfactual.  
 Throughout the remainder of the discussion, I will explicitly and implicitly 
reference a hypothetical counterfactual (e.g., a prospective policy intervention) in which 
the X is exogenously changed from Xpre  to Xpost   (from pre-intervention to post-
intervention). Without loss of generality, I write Xpost = Xpre + ∆, where ∆ represents the 
relevant distribution of counterfactually imposed increments to Xpre (e.g., as in a policy 
intervention).  Note that, strictly speaking, Xpre, Xpost and ∆ are random variables because 
their possible values vary across the relevant population of individuals with differing 
probability densities, but these random variables differ in character from X and Y (which, 
of course, are also random variables).  Unlike X and Y which are components of the DGP; 
Xpre , Xpost  and ∆ are deterministic in the sense that, for any individual in the relevant 
population, their values are imposed by the policy maker and/or researcher as part of the 
relevant counterfactual.  Note that, for this reason, Xpre and Xpre + ∆, are independent of 
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all other variates germane to the specification, identification, and estimation of the relevant 
EP. So is ∆. To Xpre and Xpre + ∆ there correspond potential outcomes YXpre  and  YXpre + ∆, 
respectively.  The relevant EP is based on the counterfactually defined entities Xpre,  ∆, 
YXpre  and  YXpre + ∆.   
2.2 Specifying the Effect Parameter of Interest in the GPOF 
 To facilitate the discussion on the proposed approaches in this dissertation, two 
empirical settings are considered. In chapter 3, estimation of the birth weight effect of a 
hypothetical intervention that effectively bans pregnant women from smoking during their 
pregnancy is considered. In chapter 4, the illustrative empirical example focuses on 
estimating the medical care cost of a hypothetical event that increases BMI of each youth 
in the US by 1 unit. Throughout this chapter except in the last section, the latter is used to 
illustrate specification, identification, and estimation of an EP in the GPOF. The 
components of the relevant counterfactuals are 
 Xpre ≡ the random variable representing the pre-counterfactual distribution of BMI 
 among the youth in the US. 
 ∆  ≡ a one-unit increase to the pre-counterfactual level of BMI to each individual 
 in the relevant population.  
Formally, I seek to estimate the following average incremental effect (AIE) 
 AIE(∆) = E[YXpre + ∆] ‒ E[YXpre]     (1) 
where ∆ = ‒1, YXpre  is the potential outcome (PO) corresponding to X
pre, [i.e., the medical 
care cost that corresponds to the pre-counterfactual distribution of BMI]. YXpre + ∆ is the PO 
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corresponding to Xpre + ∆  [i.e., the medical care cost that corresponds to the post-
counterfactual distribution of BMI where each youth has one-unit higher BMI]. Thus, the 
AIE in (1) is the average incremental medical care cost effect of a one-unit increase in BMI 
across the entire youth population in the US. 
 Even though Y has an observable version (viz., Y), the EP [e.g., (1)] cannot be 
directly estimated because YXpre  and  YXpre + ∆ are counterfactual entities (the pre- and post-
counterfactual POs) and, therefore, are at least partially unobservable (cannot be sampled). 
In fact, one may only have data on either YXpre or YXpre + ∆ but not both. In other words, it 
is not possible to observe the distribution of the medical care cost for the entire youth under 
two different BMI distributions at the same time. Therefore, in general, attempts to 
accurately (consistently) estimate the EP with observable data (X and Y) will be futile 
because the EP (which is inherently counterfactual) in no substantive way coincides with 
the observable data from X and Y (which is inherently factual).  
2.3 Conditional Potential Outcome Model, and Identification and Estimation of an EP 
 Counterfactuals are at the heart of causal inference. In the previous sections, I 
discussed specification of the EP within the GPOF based on relevant counterfactuals. The 
problem is, however, that these counterfactuals are only partially observable i.e., although 
one may have data for the X and the Y for the entire population, it is virtually impossible 
to have data on all the relevant counterfactual outcomes for anyone in the population. 
Therefore, without a rigorous procedure that formalizes the conditions under which the 
counterfactuals are in congruity with the observed version of the relevant random variables, 
one cannot simply use the latter to estimate causally interpretable EP and make inference 
about it. 
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 Terza (2019a) discusses regression-type modeling of the potential outcome that can 
be used to bridge the gap between the counterfactual object of interest (the EP) and the 
factual data (sampled from X and Y) to be used for estimation. Terza (2019a) refers to such 
modeling of the potential outcome as the conditional potential outcome model (CPOM). 
The CPOM provides a basis on which to build conditions under which one can substitute 
observable version of the X and the Y for their counterfactuals (more on this later). This 
in turn ensures identification of the specified EP. 
  The CPOM can be defined at any level of parametricity. Throughout the discussion, 
I define a fully parametric (FP) version of the CPOM. Conditioning on a vector of control 







, X*,V; π)      (2) 
where pdf(A|B) is the conditional pdf of A given B, f( . ) is a known function whose value 
is determined by the scalars and vectors in the bracket. π is a vector of unknown regression 
parameters (henceforth I refer to π as the vector of deep parameters). Using the CPOM, it 
is possible to rewrite the EP [e.g., (1)] by exploiting the regression-like conditional mean 
function that (2) implies. It follows from (2) that 
 E[Y
X*
|V] = m(X*,V; π)      (3) 
Note that, because (2) is known, the conditional mean function (3) also has known form. 
Using the law of iterated expectations and (3), (1) can be rewritten as 
 AIE(∆) = E[m(Xpre+ ∆, V; π)] ‒ E[m(Xpre, V; π)]   (4) 
12 
It is clear from (4) that if we had a consistent estimator for the vector of deep parameters π 
(say, π̂) and V were fully observable, then we would be able to consistently estimate (4) 
using its following sample analog3 









i=1   (5)     
where Xi
pre
 and ∆i are the counterfactually imposed values of X
pre and ∆, respectively, for 
the ith member of the sample of size n (i = 1, ..., n) and Vi is the value of the vector of 
controls sampled for the ith observation. Before embarking on the consistent estimation of 
the deep parameters of the model, identification must be established at two levels (Terza, 
2019a). Below I discuss these two levels of identification. 
2.3.1 Non-parametric Conditions for Identification of the CPOM 
 First, aside from any particular parametric specification one must show that the 
CPOM is non-parametrically identified. In the context of the CPOM in (2), according to 
Terza (2019a), non-parametric identification of the EP [e.g. (4)] is established if 
 pdf(Y|V, X) = f
(Y
X*
|V)(Y, V, X; π)     (6)       
In other words, the EP is identified if the conditional pdf of Y given V and X can be 
obtained by substituting X and Y for X* and Y
X*
 in (2), respectively. Terza (2019a) details 
conditions under which such substitution is legitimate.  These conditions are: i) the 
 
3 The asymptotic standard error of (5) can be obtained using the approach in Terza 
(2016a, 2016b, 2016c, 2017). 
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conditional independence assumption (CIND) which requires that, conditional on V, Y
X*
 
be independent of X; ii) Conditional Outcome Invariance which holds if 
  (Y
X*= a
 | V, X*= a) =  (Y | V, X = a) 
where “a” is a value in the support of the conditional distribution. ii) implies that 
conditional on V it should not matter to the value of the outcome whether X = a is chosen 
by an agent or exogenously imposed by a policy maker. iii) Overlap which holds if  
 0 < P(X | V)(x|v) < 1  
where,  P(X | V)(x|v) denotes the conditional pdf of X given V = v evaluated at X = x. 
Overlap requires that at each value of V, X has a nontrivial but uncertain probability that 
it equals x. In the case where X is binary overlap implies that at each value of V there are 
units who are and are not exposed to the relevant policy. 
  Among the above three conditions, the CIND is the most important, and the least 
likely to be true. Intuitively, CIND implies that all other variables that confound the pure 
causal relationship between the X and the Y are included in the vector of controls V. In 
other words, the CIND guarantees that for a given V, the distribution of the observed 
outcome, Y, for those units in the population with X = Xpre+ ∆ would have been the same 
as for units with X = Xpre had ∆, have been applied to the latter group. Thus, given V, ∆ 




2.3.2 Parametric Conditions for Identification of the CPOM 
 With non-parametric identification maintained, the second level of identification to 
be established is parametric identification.4 This type of identification has been extensively 
covered in the literature and in most graduate level econometrics texts. The discussion of 
parametric identification is exclusively focused on the level of the DGP. The parameters 
of the DGP model are identified if the chosen functional forms for the relevant aspects of 
the DGP (e.g. conditional mean, higher-order conditional moments, conditional pmf/pdf, 
etc.) are such that full knowledge of the values of those aspects of the DGP would imply 
knowledge of the values of the relevant parameters. 
 Given that the CPOM is non-parametrically and parametrically identified, it 
follows that π can be consistently estimated as the maximum likelihood estimator (MLE) 
obtained as 
 π̂ = argmax ∑ q(π̆, Zi)
n
i=1       (7) 
where q(π̆, Zi) = ln[f(Y
X*
|V)(Yi, Xi, Vi; π̆)]  is the log likelihood of the ith unit in the 
sample and Zi=[Yi     Xi   Vi] is the data vector for the ith sample. 
2.4 Endogeneity in the GPOF 
 Endogeneity is one of the most common problem in empirical economic research 
that leads to inconsistent estimation of parameters of interest. Correcting for endogeneity 
bias requires a framework that facilitates a correct definition of endogeneity. The 
 
4  Note that if one cannot establish non-parametric identification as detailed in Terza 
(2019a) then subsequent discussion of parametric identification have no useful content 
from the perspective of causal inference. 
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conventional DGP-based approach is problematic in this respect as it provides ambiguous 
and self-obviating definition of endogeneity (Terza, 2019b). For instance, in a minimally 
parametric setting where only the first moment of the relevant random variables are 
specified, this approach defines endogeneity as the absence of correlation between the 
causal variable of interest and an additive error term given an arbitrarily set vector of 
controls. As discussed in Terza (2019b), this reduces the problem of endogeneity to 
misspecification of the conditional mean function. Moreover, the lack of specificity about 
the vector of controls in the conventional DGP-based approach renders the above definition 
of endogeneity ambiguous because for any vector of controls, there correspond a “true” 
parametric or nonparametric conditional mean function. 
 By taking into account of the counterfactual nature of the EP, the GPOF, on the 
other hand, provides a more consistent definition of endogeneity. In particular, the CPOM 
within the GPOF is unique because it is a known function in which a unique vector of 
essential controls, V, induces CIND between Y
X*
 and X.5 Endogeneity of the X in the 
GPOF is, thus, defined as a situation where V is only partially observable. In such cases, 
one can write V = [Xo   Xu] where Xo is a partition of V comprising a vector of observable 
control variables and Xu is a scalar representing essential unobservable element of V.  
 In the context of estimating the AIE of a one-unit increase in BMI on medical care 
cost, BMI is likely endogenous because the vector V that induces CIND between observed 
BMI and potential medical care cost includes unobservable. For example, those youth with 
 
5 Terza (2019b) defines essential control as “a vector of variates comprising all, and only, 
confounders for Y
X*
 and X.” 
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lower BMI may have different level of health consciousness that is unobservable and also 
related with medical care cost. 
 In the presence of Endogeneity, additional structure should be built that would 
resolve the identification problem caused by partial unobservability of the unique vector 
V. This structure expands the DGP to include additional (instrumental) variables and 
(possibly) concomitant assumptions about the specifications of conditional moment of the 
expanded DGP (and those variables). In chapter 4, I present an approach that corrects 
endogeneity in 2PM context for continuous nonnegative outcomes for the specific case 
where the endogenous variable is continuous.   
2.5 An Implicit Assumption in the Conventional GPOF 
 Implicit in the GPOF is that the Y is assumed to manifest either exclusively as a 
value in a specified subset on the real line or exclusively as a qualitative event. For example, 
in the empirical example where one studies the medical care cost of obesity, the Y can take 
only real values that are nonnegative. These kinds of empirical context can be analyzed 
within the conventional GPOF. But what if the Y in a given empirical context consists of 
a union of events that correspond to values on the real line and qualitative events? Suppose 
the interest is in estimating the AIE of a policy intervention that effectively bans all 
pregnant women from smoking during pregnancy on birth weight. In this case, birth weight 
is observed only for those pregnancies that end in a live birth. All other pregnancies that 
do not end in live birth have an observed outcome that is just non-live birth, not latent birth 
weight. As mentioned earlier, such outcomes ‒ that manifest either as a value on the real 
line or as a qualitative event ‒ are called Partially Qualitive Outcomes (PQO). In the next 
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chapter, I discuss how the extant GPOF is limited in handling causal inference for PQO 
























Avoiding Bad Control Bias in Partially Qualitative Regression: Causal Inference by 
Extending the Conventional GPOF  
 Drawing causal inference within the conventional GPOF is predicated on the 
assumption that the outcome of interest manifests either exclusively as a value on the real 
line or exclusively as a qualitative event. This chapter presents an approach for 
specification, identification, and estimation of an EP for cases in which the values that Y 
takes is a union of two non-empty sets: a set containing values on the real line and a set of 
qualitative event(s). I call such outcomes as Partially Qualitative Outcomes (PQO). The 
chapter begins with a description of a PQO using the running example of estimating the 
birth weight effect of a fully effective policy that bans pregnant women from smoking 
during pregnancy. To shed light on its distinctive feature, the PQO is compared to 
outcomes that are typically modeled in the context of widely known corner solution 
models, namely the two-part model (2PM) and the sample selection model. Therein, I also 
discuss the limitation of the conventional GPOF for casting a regression model. Then the 
conventional framework is extended to encompass cases where the Y is a PQO. Within the 
expanded framework, a new outcome measure is proposed that allows casting a regression 
model that would maintain all of the essential features of a PQO and enables identification, 
and estimations of a causally interpretable EP for a PQO. The proposed outcome measure 
is referred to as the P-weighted outcome – the outcome weighted by the probability that it 
manifests as a quantitative (real) value. I discuss the practicality and usefulness of this new 
measure for specifying and identifying an EP that characterize the causal relationships 
between a policy variable of interest and the PQO. Then, a regression-based estimation 
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method for such EP is detailed and using simulated data, the implementation of the method 
and the concomitant estimator of the EP is demonstrated, and its consistency is validated. 
Using data from the National Survey of Family Growth (NSFG), I apply the proposed 
model and method in estimating the AIE of a counterfactually mandated fully effective 
policy intervention that brings the smoking levels of all pregnant women down to zero on 
natility-weighted birth weight (a new measure of birth weight discussed in detail later). 
3.1 Defining Partially Qualitative Outcomes 
 The suitability of the GPOF for casting regression model is predicated on the nature 
of the outcome under consideration. The conventional GPOF is suited to cast EP for cases 
in which the outcome of interest manifests either exclusively as a value on the real line or 
exclusively as a qualitative event that would be assigned a quantitative value for analysis. 
Examples in the former category include outcomes such as wage, BMI, health care 
expenditures and so on whereas examples for the latter category are outcomes indicating a 
person’s subjective health status, whether she has health insurance, and so on. In this 
chapter I consider PQO ‒ defined as outcomes that manifest either as a value on the real 
line or a qualitative event. For example, a newborn’s quantitative health outcome is defined 
only if a pregnancy ends in a live birth. In other words, the Y from a pregnancy might 
manifest as a non-live birth or the value of a specific measure of the newborn health 
outcome of interest, such as birth weight. For the purpose of exposition and to fix ideas, as 
running example I consider specification, identification and estimation of the EP 
representing the causal effect of smoking during pregnancy on birth weight (henceforth I 
use S+B to refer to this example).  
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 Since the US surgeon general report in 1964 that publicized the adverse relationship 
between maternal smoking and infant health, many studies have been conducted with the 
aim of investigating how changes in smoking during pregnancy affect pregnancy and infant 
health outcomes. A number of studies, for instance, document that smoking during 
pregnancy would lead to miscarriages and still births (Walsh, 1994; Ness et al., 1999; 
Mishra, Dobson, & Schofield, 2000; Pineles, Park, & Samet, 2014; Hyland et al., 2016). 
Others find that maternal smoking during pregnancy significantly reduces birth weight 
(Rosenzweig & Schultz, 1983;  Evans & Ringel, 1999; Lumley et al., 2004; Lien & Evans, 
2005; Abrevaya and Dahl, 2008). Despite using standard methodologies designed for 
estimating causal effects, these studies have limitations. On the one hand, those that focus 
on the effect of smoking on whether or not a pregnancy ends in a live birth are useful in 
that they produce arguably unbiased result, but they are less than comprehensive given the 
many other health related birth outcomes that are of great interest. On the other hand, 
studies that extend beyond the live birth question ignore the PQO nature of these other birth 
outcomes by focusing (conditioning) only on pregnancies that end in live births.6 Such 
studies, including those in the S+B context, generally produce biased estimates of the 
causal effect of the X on the quantitative component of the Y because they ignore the 
likelihood that occurrence of the qualitative event is itself affected by the X.  This results 
in bias due to so-called “bad control”. Bad control is a conditioning variable that is itself 
affected by the X (more on this later)7.   
 
6 Literature from epidemiology suggests that only 60-70% of fertilized eggs results in live 
birth (Liew et al. 2015). 
 
7 Heckman and Navarro-Lozano (2004) and Wooldridge (2005) present analytical proof 
showing how the presence of a bad control in the conditioning vector of a regression-based 
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3.2 The Conventional GPOF and PQO: the dilemma 
 In general, PQO models demand special attention for two reasons. 
1) As mentioned above, conditioning on a bad control causes bias. In order to avoid this 
problem, one must take account of the qualitative component of the model in the 
specification of the relevant potential outcome. In the S+B context, accurate estimation of 
the EP requires one to incorporate into the analysis the pregnancies that end in non-live 
birth outcomes in addition to pregnancies that end in live birth. To the best of my 
knowledge, there is no empirical study that analyzes the S+B while explicitly accounting 
for the effect of smoking during pregnancy on the event that the pregnancy may end in 
non-live birth.8  
2) In such PQO contexts, as in all modeling contexts in applied econometrics, the analyst 
seeks to specify and estimate an EP (representing the causal effect of the X on the Y) that 
is real-valued using observable real-valued data on the X and the Y. In PQO models this 
is tricky because the only definition of the Y that is real-valued is one that is conditioned 
on occurrence of the qualitative event. In the S+B context, this would be birth weight 
 
model leads to inconsistent estimation of an EP. The former demonstrates their analytical 
proof using simulation. Angrist and Pischke, (2008) also discussed how a bias arises due 
to the bad control problem. 
 
8 Bad controls are well recognized in the epidemiology literature in the context of child 
health. For example, the birth weight paradox, a phenomenon that maternal smoking is 
inversely associated with infant mortality among low-birth weight babies, is well 
documented (Wilcox, 1993, 2001; Hernandez-Diaz et al, 2006). There is also a small yet 
growing literature on the problem of conditioning on live-live birth and its consequence on 
estimated parameters for different exposures during pregnancy (Suarez et al. 2018; Liew 
et al. 2015; Lisonkova and Joseph, 2015). The studies, however, rely on simulation analysis 
with the aim of quantifying the bias due to bad control rather than coming up with an 
approach that can be used to directly estimate a consistent EP. Moreover, none of them 
specifically consider the S+B case. 
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conditional on live birth. As we have seen, however, this leads to the bad control problem. 
 To overcome this dilemma, an alternative definition of the Y is suggested that is 
real-valued but is not subject to this critique; viz., the P-weighted conditional outcome 
(PCO) – the outcome weighted by the probability that it manifests as a quantitative (real) 
value. In the S+B context, this is the birth weight conditional on live birth weighted by the 
probability of that event. This measure is called as natility-weighted birth weight.9 Note 
that the Y defined in this way does not have a version that is directly observable 
(sampleable). As I will show, however, this is of no consequence for the practical 
implementation of the PCO because, despite the fact that it is unobservable (cannot be 
sampled) it can be used to not only specify the relevant EP but also to estimate it (and 
conduct inference about it) using the observable (though not entirely real-valued) data. To 
implement the PCO, a regression-based approach is proposed that involves multiplying the 
conditional probability that the qualitative event does not occur and the conditional mean 
of the quantitative component of the PQO for the appropriate sub-population. In the S+B 
context, this is the product of the probability that the pregnancy ends in a live birth and the 
conditional mean birth weight for those pregnancies that end in live birth.  
3.3 PQO and Corner Solution Models 
 It should be noted that the empirical contexts to which the proposed PQO modeling 
approach applies differs distinctly from those for which the two-part and sample selection 
models are relevant. This section discusses the distinction between the PQO modeling and 
the two widely applied modeling frameworks. 
 
9 The word “Natility” is formed by combining two words: natal and probability. 
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3.3.1 Modeling for PQO Vs the Two-Part Model 
 The support of the outcome in the 2PM proposed by Cragg (1971) is comprised 
entirely of the nonnegative real values. In the conventional 2PM setup, the part of the model 
pertaining to manifestation (or not) of zero values for the outcome (the so-called extensive 
margin) differs systematically from the part of the model characterizing the manifestation 
of the non-zero continuous or count outcome values (the so-called intensive margin). As 
we have seen, the PQO framework likewise comprises two systematically different model 
components, but its distinguishing feature is that the PQO outcome is based on a sample 
space that includes a qualitative event (corresponding to the first component of the model) 
that is not real-valued. For this reason, the outcome for the first component of the PQO 
model has no quantitative meaning. Whereas, in the 2PM the zero values of the outcome 
manifested at the extensive margin have cardinal interpretation. Therefore, the PQO and 
2PM are not applicable under the same empirical circumstances. For example, in the S+B 
illustration the 2PM is not applicable because zero birth weight is not a meaningful concept.  
For instance, it would not be appropriate to assign zero birth weights to pregnancies that 
did not result in a live birth. 
3.3.2 Modeling for PQO Vs the Sample Selection Model 
 The sample selection model proposed by Heckman (1976, 1979) is designed for 
empirical contexts in which the objective is estimation of the parameters of an underlying 
and partially latent regression model of interest. The classic example is estimation of the 
parameters of the best wage offer regression. The problem is that best wage offers (the 
outcome variable for the regression) are not fully observable. Presumably, they are only 
observable as accepted wages for those whose best wage offers exceeded their reservation 
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wages. Such restricted observability of the Y will result in bias if there are unobservables 
that are correlated with the best wage offer and the decision to accept a wage offer. The 
sample selection estimator is designed to correct for this bias.  
 In the PQO context that I consider here, there exists no such latent regression model 
of interest. For example, in the S+B context, it is difficult to conceive such an underlying 
partially latent regression that has policy relevance whose outcome is birth weight. The 
closest one can come in this context to specifying such a regression would be one in which 
the Y is birth weight as it would have manifested if all pregnancies had resulted in live 
births. Empirical analyses based on such a regression would, however, provide policy 
makers perhaps with little (no?) relevant inferential information regarding the causal effect 
of smoking during pregnancy on birth weight. In other words, in the context of the wage 
offer, analyzing a policy that affects a wage offer may be argued to matter even if a person 
chooses not to work after exposure to the underlying policy. This is perhaps because of the 
possible effect of the increase in the latent wage on future labor supply decisions or other 
contemporaneous outcomes. In the case of the S+B, however, for the subpopulation of 
pregnancies that end in non-live birth even after the relevant policy intervention, I do not 
see any reason that one would care about birth weight.10 Even if one has an interest in this 
sub-population, because the observable (factual) data on the outcome does not exist, it is 
not possible to identify the EP non-parametrically. Therefore, in the S+B context, I assume 
 
10 Note that this is different from the effect of the smoking ban during pregnancy on the 
birth weight of those pregnancies that resolve in live birth only under the policy. This group 
whose pregnancy resolution switches from non-live birth to live birth is taken into account 
in the PQO modeling. 
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that interest lies in evaluating the effect of a counterfactually mandated smoking ban during 
pregnancy on the birth weight of the subpopulation of pregnancies that end in live birth. 
3.4 The Rationale for Extending the CPOM in the Conventional GPOF 
 The salient feature of the GPOF discussed in chapter 2 is that it takes explicit 
account of counterfactuals in specifying the EP. In particular, two versions of the X and 
the Y are distinguished. In the PQO context, the definitions of the X, X* and X require no 
special consideration. For instance, in the context of the S+B example 
 X ≡ the number of cigarettes a woman smokes per day during pregnancy, 
 X*≡ distribution of counterfactually imposed smoking levels (number of cigarettes 
 per day) for the relevant population of pregnant women  
and 
 X ≡ the random variable representing the observable (factual) version of the 
 distribution of smoking levels.  
In the context of the S+B illustrative example that I consider (a counterfactual intervention 
that fully and effectively prevents (for non-smokers) and eliminates (for smokers) smoking 
during pregnancy),   
 Xpre ≡ the counterfactually mandated pre-intervention distribution of the number of 
 cigarettes smoked per day during pregnancy, and 
 ∆  ≡ ‒ Xpre  the counterfactually imposed increment to pre-intervention smoking 
 levels (representing fully effective prevention and cessation). 
In the PQO context, however, setting up the EP as in (1) is tricky because defining the Y, 
Y
X*
 and Y in the GPOF-based PQO context (and, therefore the outcome in the S+B 
illustration) is not as straightforward.   
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 The main issues in this regard clearly emerge when one attempts to define the Y in 
the S+B context. One cannot simply define it to be birth weight for the live births because 
that definition implicitly conditions on the occurrence of a live birth. This qualitative event 
is, however, itself affected by the X. So, for instance, if we try to set up a counterfactual in 
which smoking levels are increased, we are confronted with the possibility that some 
pregnancies that would have resulted in live births (with manifested birth weight) in the 
pre-counterfactual scenario would have ended in non-live births in the post-counterfactual 
scenario (without a manifested birth weight) [assuming that smoking increases the 
likelihood of a non-live birth]. How can a meaningful EP be defined based on such an 
amorphous counterfactual? This is an example of the conceptual difficulty caused by so-
called bad control – attempting to condition the analysis on a variate that is itself affected 
by the X (mentioned in 3.1 and 3.2).11 As I will argue from a technical but practical 
perspective, bad control also precludes identification of the EP (regardless of how that EP 
is defined). As part of this research, definitions for the Y, Y
X*
 and Y are proposed in the 
GPOF-based PQO context that overcome this conceptual and practical impediment. I will 
discuss such definitions in detail later.  
 In the next section, I propose a version of the Y that is real-valued and is not subject 
to the bad control critique because it takes direct account of the effect of the X on the 
probability of occurrence for the qualitative event. In the S+B context, this Y accounts for 
the effect of smoking on the likelihood of a live birth. Although the proposed definition for 
 
11 In the context of S+B, the extant literature is subject to the bad control critique as it 
focuses on birth weight conditional on live birth (see Rosenzweig & Schultz, 1983;  Evans 
& Ringel, 1999; Lumley et al., 2004; Lien & Evans, 2005; Abrevaya and Dahl, 2008). 
Therefore, results obtained in these studies are really not causally interpretable. 
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the Y does not have an observable version, as we will see, it yields a legitimate 
specification for the relevant EP and affords consistent estimation of that parameter using 
the observable data. 
3.5 Extending the CPOM to the PQO Setting 
 As discussed in section 3.4 above, finding a clear, rigorous, and useful definition 
for the Y is difficult if it is partially qualitative. Without a definition for the Y, specification 
of the CPOM in the GPOF as exemplified in (2) is not possible. In particular, if the Y is 
not real valued, specifying a pdf like (2) is not possible. Moreover, the only way to define 
the Y as real-valued in the PQO case is to set it as conditional on occurrence of the 
qualitative event. As we have discussed, however, this approach is plagued by the bad 
control problem. I seek a way around this apparent dilemma by extending the basic CPOM 
concept to allow for a PQO. 
 Recall that we are assuming that the subpopulation of interest, on which the 
empirical causal analysis is focused, comprises those for whom a quantitative outcome 
would actually (factually) be observed. For this subpopulation, I seek to specify, identify, 
estimate and conduct inference for a parameter characterizing the causal effect of a 
counterfactually imposed change in a presumed causal variable (X*) on an outcome of 
interest (Y
X*
).  For the sake of illustration, let us focus on the following version of the AIE 
as the effect parameter of interest 
 AIE(∆) = E[YXpre + ∆|Q = 0] ‒ E[YXpre |Q = 0]    (8) 
where Xpre and ∆ are defined above and YXpre  and YXpre + ∆ denote the observed versions of 
the Y that correspond with Xpre and Xpre+ ∆, respectively. Q indicates the observability of 
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the qualitative component (via the DGP) of the PQO.  Conditioning on Q = 0 is tantamount 
to conditioning on the subpopulation for whom a quantitative outcome would actually 
manifest. In the S+B illustrative example, Q = 0 denotes the subpopulation of pregnancies 
that end in a live birth. Note that I have not yet given specificity to the definition of 
(Y
X*
|Q = 0) [and, therefore, (Y
Xpre
|Q = 0)] in the present PQO context. I now turn to this 
issue. 
 To fix ideas and to build upon the GPOF discussion in chapter 2, for the Q = 0 
subpopulation, consider a random experiment corresponding to a counterfactually imposed 
version of X* whose sample space comprises the union of a qualitative event Q
X*
 (not a 
real value) and a specified subset of the real line (ℝ), say R
X*
 whose typical element is 
r
X*
 (note that it is possible that R
X*
= ℝ). Correspondingly, (Q
X*
|Q = 0)  is defined to be 
the dichotomous random variable characterizing the stochastics of the qualitative 
component of the hypothetical experiment [(Q
X*
 | Q = 0) = 1 if the qualitative potential 
outcome would occur and (Q
X*
 | Q = 0) = 0 if the quantitative potential outcome would 
occur]. In the S+B context, (Q
X*
 | Q = 0) = 0 if the pregnancy ends in a live birth at the 
counterfactually mandated level of smoking during pregnancy for those pregnancies that 
actually (factually) end in live birth. Finally, (R
X*
 | Q = 0, Q
X*
 = 0) is defined to be the 
random variable characterizing the quantitative component of the counterfactual 
experiment conditional on non-occurrence of the qualitative potential outcome; the support 
of (R
X*
 | Q = 0, Q
X*
 = 0) is R
X*
. In the S+B example, (R
X*
|Q = 0, Q
X*
 = 0) is the potential 
birth weight of pregnancies that would end in live birth at the counterfactually mandated 
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level of smoking during pregnancy for pregnancies that actually (factually) ended in live 
birth.12 
 In this context, one’s first inclination for specifying (Y
X*
 | Q = 0) might be to set it 
equal to (R
X*
 | Q = 0, Q
X*
 = 0) so that (8) would be rewritten as  
  AIE(∆)† = E[RXpre + ∆|Q = 0, QXpre + ∆ = 0]      
    ‒ E[RXpre |Q = 0, QXpre = 0]   (9) 




  at 0 and thus fails to account for 
the possible impact of the counterfactual change in Xpre on Q
Xpre 
– an effect that will surely 
influence the potential outcome (whatever its definition). For this reason, (9) will be biased 
as an effect parameter intended to characterize the causal effect of the posited 
counterfactual change in Xpre on the quantitative potential outcome of interest (whatever 





 that is required by (9). In general, bias due to bad 
control can be expected in any empirical causal analysis in which some elements of the 
vector of control variables can themselves be characterized as potential outcomes that 
would be impacted by the posited counterfactual change in the presumed causal variable. 
In the present context, I seek to avoid bad control by directly including the possible impact 
of counterfactual differences in the qualitative potential outcome in the specification of the 
 
12  To clarify this notation, consider the description for (R
X*
|Q = 1, Q
X*
 = 0) . It is the 
potential birth weight of pregnancies that would have ended in live birth at the 
counterfactually mandated level of smoking during pregnancy but did not actually end in 
live birth. This implies that those pregnancies must have had levels of smoking during 
pregnancy that is different from X*. 
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quantitative potential outcome of interest. To wit, the following specific definition for the 
generic term (Y
X*
 | Q = 0)  in (8) is proposed. 
 (Y
X*
 | Q = 0) ≡ Pr(Q
X* 
 = 0 | Q = 0) × (R
X*
 | Q = 0, Q
X*
 = 0)     
          (10) 
where, Pr(Q
X* 
 = 0 | Q = 0)  denotes the probability that, for a given version of X* , the 
counterfactual quantitative outcome would manifest for the subgroup of the population for 
whom the quantitative outcome is actually (factually) observable. In the illustrative 
example of S+B, (10) is the potential birth weight of pregnancies that would end in live 
birth at X* weighted by the probability of a live birth outcome for those pregnancies that 
actually ended in live birth. Clearly, (10) is designed to explicitly incorporate the impact 
of X* on Q
X* 
; thereby avoiding the bad control critique. Rewriting (8) accordingly we 
obtain 
 AIE(∆) = E[Pr(Q
Xpre + ∆
 = 0 | Q = 0) × (R
Xpre + ∆
 | Q = 0, Q
Xpre + ∆
 = 0)  ]   
  ‒ E[Pr(Q
Xpre
 = 0 | Q = 0) × (R
Xpre
 | Q = 0, Q
Xpre
 = 0)  ]   
          (11)  
Let us now turn to the estimation of (11) via regression methods. 
 As discussed in the chapter 2, in the GPOF, estimation of a CI parameter is 
predicated on an appropriately designed CPOM.  The present PQO context is, however, a 
bit unorthodox. First, the relevant potential outcome as defined in (10) does not have a 
directly observable counterpart in the DGP [although, as we will see later, its components 
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are identified (non-parametrically and parametrically)]. Secondly, and related to this, is the 
fact that the relevant CPOM will be defined in three parts. For the first component of the 
CPOM I assume that conditional on a vector of controls V 
 Pr(Q
X* 
 = 0 | V, Q = 0) = P(V, X* ; τQ)    (12) 
where P(.  ,  .  ;  .) is a known function whose range is the unit interval and τQ is a vector 
of unknown parameters.13 This function is typically specified in terms of a cumulative 
distribution function (cdf). Secondly, the pdf for the quantitative component is specified as  
 pdf(R
X* 
| V, Q = 0, Q
X*
 = 0) = g(r
X* 
, X* , V; τg)   (13) 
where g(r
X* 





) and τg is an unknown parameter vector.
14 Combining (11) through (13) and 
applying the law of iterated expectations we obtain 
 AIE(∆) = E[E[Pr(Q
Xpre + ∆
 = 0 | V, Q = 0) × (R
Xpre + ∆
 | V, Q = 0, Q
Xpre + ∆
 = 0)]   
  ‒ E[Pr(Q
Xpre
 = 0 | V, Q = 0) × (R
Xpre 
 | V, Q = 0, Q
Xpre 
 = 0)]] 
 = E[P(V, Xpre + ∆; τQ) × E[RXpre + ∆ | V, Q = 0, QXpre + ∆ = 0] 
 
13 To be more explicit, we might have written    
 P(V, X* ; τQ) = 𝒫(Q
X* 
 = 0 | V, Q = 0) (V, X
* ; τQ) 
 
14 To be more explicit, we might have written  
 g(r
X* 
, X* , V; τg) = ℊ(R
X* 
| V, Q = 0, Q
X*
 = 0)(rX* , X
* , V; τg). 
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        ‒ P(V, Xpre; τQ) ×E[RXpre | V, Q = 0, QXpre = 0]] 
 = E[P(V, Xpre + ∆; τQ) m(V, X
pre + ∆; τg) ‒ P(V, X
pre; τQ) m(V, X
pre; τg)]  
                (14) 
where  
 m(V, X*; τg) = E[RX* | V, Q = 0, QX* = 0]= ∫ rX*g(rX* , X
* , V; τg) drX*R
X*
 
The third component of the CPOM is 
 pmf(Q
X* 
| V) = h(Q
X* 
, V, X* ; τQ) = P(V, X
* ; τQ)
1−Q
X* [1 ‒  P(V, X* ; τQ)]
Q
X*  
          (15) 
which says that the parametric specification for the likelihood of the qualitative potential 
outcome in the first component of the CPOM for the relevant subpopulation (Q = 0) as 
given in (12), also holds true for the population at large (i.e., regardless of the value of Q). 
 Now if we had consistent estimates of the “deep” parameters of the model τQ and 
τg, (say ?̂?Q and ?̂?g) we could consistently estimate the targeted effect parameter in (14) as  





+ ∆i; τ̂Q)Q = 0 m(Vi, Xi
pre
+ ∆i; τ̂g) 




; τ̂g)}  (16) 
where ΣQ = 0 indicates summation over the subsample of observations for whom Qi = 0 
and nQ = 0 denotes the size of that subsample.  
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 Before embarking on the consistent estimation of the deep parameters of the model, 
identification must be established at the two levels as discussed in sections 2.3. First, aside 
from any particular parametric specification, the CPOM must be shown to be non-
parametrically identified. In the context of the CPOM that I have posited here, according 
to Terza (2019a), non-parametric identification is established if it can be shown that the 
following DGP versions of (13) and (15) are valid 
 pdf(R | V, Q = 0) = g(r, X, V; τg)     (17) 
and 
 pmf(Q | V) = h(Q, V, X; τQ) = P(V, X; τQ)
1−Q[1 ‒  P(V, X; τQ)]
Q
   
          (18) 
In other words, the model (i.e. the CPOM) is non-parametrically identified if the relevant 
aspects of the DGP can be obtained by simply substituting the observable versions of the 
X and the relevant components of the Y (viz., X, Q and R) for their counterfactual 




) into the CPOM. As presented in section 2.3, the most 
important of these conditions, and the least likely to be true, is CIND between the potential 





 are independent of X conditional on V. Among the list of sufficient conditions for 
non-parametric identification, CIND is the most troublesome because it is not only unlikely 
to be true but it is also untestable. For the present discussion, I will maintain that CIND 
and the other conditions for non-parametric identification [(as discussed in Terza (2019a) 
and reviewed in section 2.3] hold.  
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 With non-parametric identification maintained, the second level of identification to 
be established is parametric identification.15 As discussed in section 2.3.2, the parameters 
of the DGP model are identified if the chosen functional forms for the relevant aspects of 
the DGP (e.g. conditional mean, higher-order conditional moments, conditional pmf/pdf, 
etc.) are such that full knowledge of the values of those aspects of the DGP would imply 
knowledge of the values of the relevant parameters. Functional forms for P(V, X; τQ) and 
g(r, X, V; τg) are chosen that afford parametric identification of τQ and τg. 
 Given that the CPOM is non-parametrically and parametrically identified, based on 
(17) and (18), the parameter vectors τQ and τg can be estimated using the following MLE 




i=1 τ̌Q, ZQi)      (19) 





τ̌g, Zgi)      (20) 
where, n denotes the size of the full sample, nQ = 0 is the size of the subsample for whom 
Q = 0, qQ(τ̌Q, ZQi) = ln[h(Qi, Vi, Xi; τ̌Q)] , qg(τ̌g, Zgi) = ln[g(Ri, Vi, Xi; τ̌g)] , 
Z𝒬i = [Qi     Vi      Xi]  and Zgi = [Ri     Vi      Xi] . The asymptotic standard errors of the 
estimators in (19) and (20) can be obtained by using the approach in Terza (2017). 
3.6 Simulation Study 
 In this section, I demonstrate the implementation of the estimators in (19) and (20) 
for the PQO model and validate the consistency of the proposed AIE estimator using 
 
15  Note that if one cannot establish non-parametric identification as detailed in Terza 
(2019a) then subsequent discussion of parametric identification have no useful content 
from the perspective of causal inference. 
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simulated data. For the sampling design of the simulation study, consider the case in which 
(12) and (13) are specified such that 
 R
X*
 ≡ (0, ∞) 




, X*, V; τg) = gg(YX*; VτgV+ X
*τgX, κ, σ) 
where  
 gg(A; b, c, d) = 
νν
dA√νΓ(ν)
exp(z√ν ‒ u)     (21) 




 , u = ν × exp(|κ|z), and Γ( ) is the gamma function. The three parameter 
Generalized Gamma (GG) distribution is chosen for simulating values for the quantitative 
component because it is very flexible distribution that subsumes several known 
distributions that are commonly used for non-negative random variables, such as the 
Weibull, Exponential and Log-normal among others. 
3.6.1 The Simulated Data Generator 
 The data generator has two parts, i.e., (17) and (18). (18) generates a binary 
outcome indicator for the qualitative component of the model representing whether or not 
a pregnancy ends in a live birth. For this part, data will be generated for the full sample 
following the assumption in (15) that pregnancies that do and do not end in live birth have 
the same parametric specification for the likelihood of the qualitative potential outcome. 
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The second part, given in (17), generates strictly positive values for the quantitative 
component representing birth weight values of the pregnancies that end in live birth. Note 
that for this component, data is generated for the sub-sample of the pregnancies for which 
the simulated outcome for the first part of the generator is one that resulted in live births.  
 A uniformly distributed random variate data generator is used to simulate the data 
vectors Vo and Xo for the observable random variables V and X, respectively. To obtain 
these vectors, I specify the mean and variance of Vo and Xo. The change in the policy for 
the targeted AIE is given by Δ
o = ‒ Xo. Note that the post-intervention vector, Δo + Xo, is 
a null vector. For the qualitative component, I specify an indicator function  
 (Q
X*
 | Q = 0) = 0  if  I(VoτQV
o  + XoτQX
o + ε > 0) = 1    (22) 
where, ε ∼ N(0, 1), τQ
o =  [τQX
o     τQVo
o ′] where  τQVo
o ′ = [τQV
o      τQo
o ] denotes the vector of 
specific parameter values chosen for the sampling design of the simulation (detailed later). 
 Because birth weight is a strictly positive outcome, the quantitative component of 
the data generator simulates values from a GG random variable. Since the GG is a 
continuous random variable, I rely on the inverse transform theorem to generate values of 
the random variate (Ross, 1997). To implement the inverse transform method, I need to 
know the cdf of the GG variate and its inverse. According to Stacy and Mihram (1965), the 
conditional cdf of the GG variable is 
     








o, Vo, Xo, τg
o , κo, σo) =       (23) 
     1 ‒ 




 if p < 0 
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,       
a =  
exp(VoτgV















o =  [τgX
o        τgVo
o ′] where τQVo
o ′ = [τgV
o        τgo
o ] is 
the coefficient vector for the linear index component in a. Note that 




= SG(ν, ( Yo a⁄ )
p
), where SG(h, j) is the standard gamma cdf evaluated at h with 
shape parameter j. Manning et al (2005) provides a crosswalk between this 
parameterization (a, ν and p) and the one introduced in the expression for the GG pdf in 
(21).   From (23) it can be shown that when p > 0, we have 




(U[0, 1], Vo, Xo, πg
o, κo,  σo)   
  = a × γ‒1(ν, Γ(ν)U[0, 1])
1





(U[0, 1], Vo, Xo, πg
o, κo,  σo)  denotes the inverse of the GG cdf as given 
in (23),  γ‒1(d', j) denotes the inverse incomplete gamma defined such that if j = γ(d', k), 
then k = γ
‒1
(d', j) and U[0, 1] is a unit uniform variate. It is not easy to get the inverse 
incomplete gamma function directly in Stata/Mata, but one can get it indirectly. Yang 
(2016) derived the following equivalent expression for (24) which can be simply 
implemented in Stata/Mata 




p      (25) 
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where SG
‒1(a, U[0, 1]) denotes the inverse standard gamma variate with shape parameter 
a. Using (25) and by choosing the values τgo , κo,  σo, I generate the sample values of the 
quantitative component for the subsample such that (Q
X*
 | Q = 0) = 0. 
 Once the two components of the data are generated, we obtain the true AIE in (14) 
using the specifications  
 P(Vo, Xo; τQ
o )  = Φ(VoτQV
o  + XoτQX
o ) 
and  
 m(Vo, Xo; τgo ) = exp [V
oτgV




)  ln((κo)2) 










where Φ( ) and m( ) denote mean values of the binary and the GG variates, respectively. 
3.6.2 The Sampling Design and the Simulation Results 
 The main motives for the simulation are to demonstrate the implementation of the 
PQO modeling using the estimators in (19) and (20), and to validate the consistency of the 
EP in (14). For the linear index component coefficient vector of the probit specification 
τQ
o =  [τQX
o        τQVo
o ′]  where τQVo
o ′ = [τQV
o        τQo
o ]  for which the following parameter 
vector of values is specified. 
 τQ
o  = [0.15        ‒0.5       12] 
Here, I assign τQX
o  = 0.15 for Xo in the probit model to mimic the evidence that smoking 
during pregnancy increases [decreases] the probability that a pregnancy ends in a non-live 
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birth [live birth]. To obtain sample values of the GG variate representing birth weight for 
pregnancies that end in live birth, I specify the parameter values for the linear index 
component coefficient vector τg
o =  [τgX
o        τgVo
o ′] where τQVo
o ′ = [τgV
o        τgo
o ] and for the 
two ancillary parameters κo and σo as follows: 
 τg
o  = [‒0.004       0.002       8] 
  κo = 0.95 and σo = 0.175  
 Like I do for the qualitative component, I impose a negative value (τ
gX
o
 = ‒0.004) 
for Xo  in the GG model to allow a reduction in birth weight due to smoking during 
pregnancy. To obtain Vo  and Xo , I specify the mean and variances as E[V
o
] = 27 , 
E[X
o
] = 1.75, Var[V
o
] = 49 and Var[X
o
] = 1, where E[  ]  and Var[  ] denote the mean and 
variance functions. These values are chosen to get a distribution closer to birth weight for 
the outcome variable. As it can be seen on table A1 in appendix I, the average value of Yo 
is 2939 which is somehow close to an average birth weight in grams. 
 After simulating the data vectors Vo , Xo , and Yo  for (Q
X*
 | Q = 0) = 0, I obtain 
estimated values for the probit and the GG model deep parameters by applying the M-
estimator in (19) and (20). Based on these values, I estimated the AIE and compared it to 
the true AIE obtained by plugging the specified parameter values into (16). A super sample 
of 2,000,000 observations is used to calculate the true AIE. To examine the consistency of 
the AIE estimator, I simulated samples of increasing size using the data generators detailed 
above. I then applied the MLE estimator for the targeted EP and calculated the absolute 
percentage bias (APB) of the estimated AIE for each of the simulated data of sample size 
n. The APB is calculated using the formula 
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 denote the estimated and the true AIE values, respectively. 
 Table 1 presents the results of the simulation. In general, the results provide 
evidence for the consistency of the AIE estimator. For instance, the APB of the estimated 
AIE is 11.7% when the model is simulated using a sample of 25,000 observations for the 
entire population of which 15181 observations are used to estimate the deep parameters of 
the GG model and the corresponding AIE. This APB further decreases to 5.4% [0.7%] 
when the entire sample size increases to 100,000 [250,000] of which the relevant 
subpopulation has 60,168 [150,067] observations. Therefore, the PQO modeling approach 
and the ML estimator I proposed provide consistent estimate for the specified AIE.  
3.7 Application: Smoking and Natility-Weighted Birth Weight 
 This section presents an empirical application of the proposed PQO regression 
model to estimate the natility-weighted birth weight effect of a counterfactual intervention 
that fully and effectively bans smoking during pregnancy. I also estimate the AIE of the 
same hypothetical intervention on the conventional measure of birth weight that is subject 
to a bias due to bad control.  
 I use a probit specification to model the probability that a pregnancy ends in a live 
birth and a GG model to characterize birth weight for the sub-population of pregnancies 
that end in live birth. In particular, I estimate the AIE in (14) based on the M-estimators in 
(19) and (20) and using the following specific functional forms for the probability that a 
pregnancy ends in a live birth and for the conditional mean birth weight given that the 
pregnancy ends in a live birth 
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 P(V, X*; τQ) = Φ(VτQV+ X
*τQX) 




)  ln((κ)2) 










       Apart from the bad control problem, as discussed in section 3.5, estimating 





X conditional on V. In other words, the potential resolution of a pregnancy (whether or not 
it ends in a live birth) and potential birth weights are independent of the observed smoking 
level given the vector of observed variates. This is unlikely to hold in observational setting 
as one can imagine a number of unobserved factors such as propensity to engage in risky 
behavior, maternal health endowment and so on that correlate with both prenatal smoking 
and pregnancy as well as birth outcomes (Grossman & Joyce, 1990). This implies that 
smoking is endogenous. 
 Studies in the conventional birth weight literature find mixed evidence on the 
endogeneity of smoking during pregnancy. Using a difference-in-differences approach, 
Fertig (2010), for instance, finds that smoking was associated to a 261 grams reduction in 
birth weight in the year 2000 up from a reduction of 160 grams in 1958 sample. She argues 
that as information about the harms of cigarette smoking become widespread, women from 
higher socioeconomic status quit smoking at a larger rate implying that the observed 
association in the result from the year 2000 is likely confounded by unobserved factors that 
is correlated with smoking behavior of pregnant women from low socioeconomic status 
group. Evans & Ringel, (1999) use tax hike as instrumental variable and find that smoking 
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during pregnancy reduces birth weight between 300 grams and 600 grams, a significantly 
larger reduction than the Ordinary Least Squares (OLS) estimates. This result suggests that 
there is probably advantageous selection – women with worse maternal health tend to quit 
smoking more than pregnant women whose health endowment during pregnancy is higher. 
On the other hand, Lien and Evans (2005) used a cigarette tax hike in four states and 
matched each state to similar control states. They find that smoking reduces birth weight 
by 185 grams. Their IV estimate was not, however, statistically different from the OLS 
estimate suggesting that smoking is perhaps exogenous. In addition to the fact that these 
studies are subject to bias due to bad control, the inconsistency in the results indicate that 
selection into smoking is also a concern. 
3.7.1 Data Source and Descriptive Statistics 
 I use data from the National Survey of Family Growth (NSFG). NSFG is a 
nationally representative of women 15-44 years of age. From 2015 onwards the age range 
expanded to 15-49. Unlike many other data sources, NSFG asks each respondent woman 
detail information about her pregnancy history covering five years prior to the interview 
date. Importantly, it has information about conception and end of month information on 
each pregnancy, how each pregnancy ended and the smoking behavior of the mother during 
each pregnancy. I use data from survey periods 2002, 2006-2010, 2011-2013 and 2013-
2015. 
 The outcome variables I consider are an indicator for whether the pregnancy ends 
in a live birth or not, and birth weight in grams for those pregnancies that end in live birth. 
The number of cigarettes smoked per day is the main policy variable in the empirical 
analysis. Given the possibility for endogeneity of observed level of smoking during 
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pregnancy, as discussed in chapter 2, one would need to expand the DGP by exploiting an 
appropriate empirical identification strategy such as state cigarette tax rate as an instrument 
to deal with the endogeneity of smoking. Because I use the public access version of the 
data that do not have state identifier for pregnancies, I am not able to match state cigarette 
tax information to the pregnancies in the dataset. Therefore, the result can have a causal 
interpretation only under the strong assumption that smoking during pregnancy is 
exogenous conditional on the vector of observable control variables such as marital status 
during pregnancy, age at pregnancy, educational attainment, and race. 
 Table 2 presents the descriptive statistics of the data for the full sample and by live 
birth status of pregnancies. For the full sample, 21.6% of pregnancies do not end in live 
birth. As expected, relative to women who had a live birth, smoking rate is higher (by 5 
percentage point) among women whose pregnancies did not end in live birth. Table 3 
compares live birth outcome, birth weight and other characteristics of the sample by 
smoking status. Women who smoke during pregnancy have a 7.2 percentage point lower 
live birth rate than those who do not smoke. Among women who have live births, the 
average birth weight was 151.5 grams (0.33 pound) lower for infants born from mothers 
who were smoking during pregnancy. 
3.7.2 Estimation Results  
 Table 4 presents the deep parameter estimates for the probit and the GG regression 
models. Columns 1 and 2 show the deep parameter estimates of the probit and the GG 
specifications, respectively. It can be seen that the coefficient on the number of smoking 
variable in both the qualitative and quantitative components of the PQO model are negative 
and statistically significant implying that smoking has a negative effect on natility-
44 
weighted birth weight. The statistically significant coefficient in the probit model provides 
empirical evidence that bad control is indeed a concern in the context of S+B, suggesting 
that one cannot interpret an EP based only of the quantitative component of the model. 
 In column 1 of table 5, I present the AIE for the natility-weighted birth weight that 
has a direct causal interpretation (under exogeneity of smoking during pregnancy) and the 
AIE estimated based on the conventional measure of birth weight that is subject to the bad 
control problem. The latter is biased because it ignores the qualitative component that 
accounts for the effect of smoking during pregnancy on the probability that the pregnancy 
ends in a live birth. The estimated AIE shown in column 1 suggests that a fully effective 
smoking ban during pregnancy would increase natility-weighted birth weight by 32.7 
grams (0.072 pounds). The result in column 2 shows that the policy increases the 
conventional measure of birth weight by 11.24 grams (0.025 pounds). This result, however, 
cannot have a causal interpretation even when smoking is truly exogenous.  
 It should be noted that the estimates in both cases are smaller than most of the 
estimates reported in the literature on the effect of smoking during pregnancy on birth 
weight. This is because the targeted effect parameter in our case applies to the entire 
population of pregnant women whose pregnancy ends in a live birth while the estimates in 
the conventional literature aims to target the subpopulation of pregnant women who 
actually smoked during pregnancy. In the language of the treatment effect literature, the 




3.8 Summary, Discussion and Conclusion 
 A new regression-based approach is developed for specification, identification, and 
estimation of causally interpretable EP for an outcome of interest that manifests as either a 
value in a specified subset of the real line or a qualitative event -- a partially qualitative 
outcome (PQO). A PQO requires special attention because the only version of it to which 
the conventional form of the GPOF can be applied to is subject to bias due to the bad 
control problem. An outcome measure is proposed that maintains all of the essential 
features of a PQO but is entirely real-valued and is not subject to the bad control critique; 
the P-weighted outcome – the outcome weighted by the probability that it manifests as a 
quantitative (real) value. The practicality and usefulness of this new measure for specifying 
and identifying effect parameters that characterize the causal relationships between policy 
variables of interest and the PQO is discussed. Moreover, a regression-based estimation 
method is detailed for such effect parameters and, using simulated data, demonstrate its 
implementation and validate its consistency for the targeted effect parameter. The proposed 
approach is illustrated by conducting an empirical study to analyze a counterfactually 
mandated fully effective policy intervention that brings the smoking levels of all pregnant 
women down to zero on the natility-weighted birth weight. Using the NSFG public access 
data, I find that the smoking ban improves natility weighted birth weight, on average, by 
32.7 grams over the entire sub-population of pregnancies that end in live birth. The 
corresponding AIE estimated for birth weight as in the conventional approach is an 11.24 
grams increase in birth weight. While the latter result cannot be interpreted as causal effect, 
the causal interpretability of the AIE for natility-weighted birth weight relies on the 
assumption that smoking during pregnancy is exogenous conditional on the vector of 
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observable variables included in the model. In practice, there may be several unobservable 
confounders such as risky behavior of pregnant women, maternal health endowment and 
so on that could invalidate this assumption, making causal interpretability of the estimates 
questionable. As an extension to this work, I plan to incorporate such endogeneity into the 





















Correcting Endogeneity Bias in Two-Part Models: Causal Inference from the Potential 
Outcomes Perspective 
 The two-part model (2PM) is one of the most widely applied empirical modeling 
and estimation framework in empirical health economics.16 17 It applies to cases in which 
the outcome variable is nonnegative with a non-trivial number of units having an observed 
value of zero. By design, the 2PM has two distinct components; a qualitative (binary) 
extensive margin (EM) characterizing an individual’s participation (or not) in a specified 
activity, and an intensive margin (IM) representing the individual’s level of activity 
(conditional on participation as determined at the EM). The 2PM allows the process that 
determines observed zero outcomes to systematically differ from that which determines 
non-zero observations.  
 In this chapter, a regression-based potential outcomes approach is developed to 
policy relevant causal inference in the context of 2PM in which the causal variable of 
interest is a continuous endogenous variable. In particular, the estimation objective is the 
AIE specified in (1). Endogeneity of the causal variable of interest is a common problem 
in 2PM like in any other econometric models that are specified to obtain CI parameter. 
 
16 The notion of explicitly accounting for a discrete mass at zero of a random variable was 
highlighted by Aitchison (1955). He derived the mean and variance of such random 
variables and demonstrated the enormous improvement in terms of obtaining a better fit by 
comparing the relative performance of fitting a truncated and a standard Poisson models to 
observed data on number of children in a household. The two-part model (2PM) was 
introduced in a regression framework by Cragg (1971). 
 
17  The seminal work by Duan et al (1983) was the first to apply the 2PM in health 
economics and health services research. Few of the numerous applications of the 2PM in 
health care and health service research include Biener et al 2020, Burney et al. 2016, Hyun 
et al. 2016, Li et al. 2016, Liu et al. 2010, Madden 2008, Buntin and Zaslavsky 2004, Ross 
and Chaloupka 2003, and Bradford et al. 2002.  
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Endogeneity is defined from the potential outcomes perspective detailed in chapter 2 as the 
partial observability of the unique conditioning vector, V, that induces CIND between the 
observed version of the X and the potential outcomes Y
X*
. With this definition, I extend 
the generic fully parametric 2PM (FP2PM) framework developed in Hao and Terza (2018) 
to encompass cases in which the X is endogenous. As pointed out in chapter 2, when 
endogeneity is present, an additional structure is needed to identify a CI parameter. The 
main objective of this chapter is specification of such a structure within the GPOF for the 
2PM and a version of the estimator in (5) for the AIE in (1) that can be estimable using 
observable data. The chapter also highlights on the advantages of casting the causal 
inference problem in a FP2PM framework. These advantages include setting up of two 
important statistical tests. The performance of the proposed approach relative to other 
alternatives that are widely used to deal with endogeneity in the context of nonlinear 
models in general and the 2PM in particular is also demonstrated through a simulation 
study. In the last section, I implement the proposed approach to an empirical setting where 
the object of interest is estimation of the effect of a one unit increase in BMI on medical 
care spending among the youth in the US. I also estimate the medical care cost of a 
hypothetical change that moves all youth in the US from an average normal BMI to an 





4.1 Specifying a Generic FP2PM with a Continuous Endogenous Variable within the 
GPOF 
 Here I extend the generic FP2PM specified within the GPOF in Hao and Terza 
(2018) to accommodate cases where the X is endogenous variable. This generic 
specification encompasses all the 2PM in the literature and also allows implementation of 
two important null hypotheses: “no 2PM is needed” and “the X is exogenous”.  
 The salient feature of the 2PM is that the process that determines zero outcome 
values is allowed to systematically differ from that which determines strictly positive 
values for the outcome variable. Below I describe the specification of a generic FP2PM for 
the EM and IM components in which the X is a continuous endogenous variable. The 
model is specified using the GPOF notation to facilitate specification of a conditional mean 
function that is amenable for specifying CI parameter. 
4.1.1 The Extensive Margin 
 Y
X*
 = 0 iff  U <  G
(ζEM




, X*, Xo, Xu; τEM)   
          (27) 
where U  is uniformly distributed on the unit interval and     
 G
(ζEM




, X*, Xo, Xu; τEM) is the conditional cumulative density function (cdf) of 
(ζ
EM
*  | Xo, Xu), written as a function of Xo, Xu and a vector of deep parameters for the EM, 
τEM, evaluated at ζEM (an unobserved parametric threshold).  G(A|C)
EM
(A, B, C; ψ) denotes a 
conditional cdf of A conditional on C written as a function of A, B, C and the parameter 
vector ψ. To indicate that the X is endogenous, the unobservable scalar Xu is explicitly 
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included in (27) and in subsequent specifications for the IM as well as for the conditional 
pdf detailed later.  
4.1.2 The Intensive Margin 











) iff  
 U ≥  G
(ζEM
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*  | Y
X*











*, Xo, Xu; τIM)




*  |  Y
X*









> 0 ,  Xo  and Xu , written as a function of YX* ,  X
*,  Xo ,  Xu , an unknown 
parametric threshold ζ
IM
 and a vector of deep parameters of the distribution for the IM, 
τIM.  
 The systematic difference between the EM and IM components of the 2PM can 
arise from two sources. The first is when the structure (or the general function form) that 
generates the zero values differs from that which generates the strictly positive values. 
Second, even when there is no such structural difference (NSD) between the EM and the 
IM, the 2PM may still be needed if the deep parameters of the functional form for the two 
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components differ. Unlike traditional 2PM specifications, the IM in (29) is written as a 
truncated cdf with a parametric and unknown truncation point. Hao and Terza (2018) show 
that such a truncated cdf specification for the IM is sufficient to set up a likelihood ratio 
test for the null that “there is no need for 2PM”. 
 The conditional pdf of (Y
X*




 | Xo, Xu) =  f(Y
X*
 | Xo, Xu)
(Y
X*
, X*, Xo, Xu; π)   
   = [ G
(ζEM
*









   × [(1 −  G
(ζEM




, X*, Xo, Xu; τEM))  











, X*, Xo, Xu; τIM)  
1 ‒ G
(ζIM
*  | Xo, Xu)
IM
(ζIM, X






          (30) 
f( . )( ; ) in the first equality denotes a known conditional pdf of YX*  given  Xo  and Xu , 
written as a function of Y
X*
, Xo, Xu and the vector of deep parameters π = [τEM












, X*, Xo, Xu; τIM) is the conditional pdf of YX*  given  Xo 
and Xu for the subpopulation whose YX*  passes a parametric threshold ζIM.  The indicator 
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          (31) 
Using the law of iterated expectation and (31), we can rewrite the EP in (1) as 
 AIE(∆) = E [(1 ‒ G
(ζEM





























pre+∆, Xo, Xu; τIM)
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pre, Xo, Xu; τIM)
]   
          (32) 
The AIE in (32) is not, however, identified because the underlying conditional pdf in (30) 
is written in terms of counterfactual entities that are not part of the DGP from which sample 
values are drawn. The AIE also contains a scalar control Xu that is part of the DGP yet is 




4.2 Identification of the Generic FP2PM with a Continuous Endogenous Variable 
 As discussed in chapter 2, identification of the AIE in (32) requires existence of a 
vector of control variables that induces CIND between X and Y
X*
. Suppose V = [X
o
    Xu] 
is such vector where Xo  is represents the observable partition of V and  Xu  is a scalar 
comprising of the additional relevant unobservable controls needed to induce conditional 
independence. This implies that one can legitimately write the conditional pdf of Y given 
V and X by substituting X and Y for X* and Y
X*
 in (30) which yields 
 pdf(Y | X, Xo, Xu) = [ G(ζEM




, X, Xo, Xu; τEM) ]
I(Y = 0)
 







, X, Xo, Xu; τEM))  




















Although the conditional pdf in (33) is written virtually in terms of factual entities that are 
elements of the DGP, it contains a scalar Xu that is essential but unobservable. As a result, 
it is not possible to solely base identification and estimation of the AIE in (32) on the 
feature of the DGP shown in (33). Instead, one needs to impose additional structure that 
expands the DGP to include additional variables and relevant assumptions about the 
specifications of the conditional moments of the expanded DGP. Next, I present the 
proposed approach that adds structure to (33) to identification of its deep parameters and 
hence the AIE in (32). Note that the approach is specifically relevant to the 2PM for 
continuous nonnegative outcome with a continuous endogenous variable. 
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4.2.1 A Generalized Control Function Approach 
 A generalized control function (GCF) is specified based on a flexible distributional 
assumption for the endogenous variable. This approach is a specific case of an 
encompassing modeling and estimation framework proposed by Terza (2019c) for a very 
general class of nonlinear models involving an endogenous presumed causal variable. 
Under regular instrumental variables (IV) assumptions detailed later in this section, the 
GCF is a deep residual that necessarily induces CIND between X and Y
X*
. This property 
of the GCF is not satisfied by design in many other control function or predictor 
substitution approaches.18  
 As in Terza (2019c), the relationship between X and Xu implied by a fully specified 
parametric distribution for X can be written as 
 X = H-1(Xu,W; δ)       (34) 
where H-1( . ) is the inverse of a known cdf of X given the vector W = [Xo     W
+], W+ is a 
vector of identifying instruments and δ is the parameter vector to be estimated.19 The 
expression in (34) can be thought of as one resulting from the inverse transform theorem 
where Xu  is a unit unform random variable (Ross, 1997). Thus, given that H
-1( . )  is 
continuous, we have 
 Xu = H(X,W; δ)        (35) 
 
18 Carlson (2020) demonstrates how the CIND assumption fails to hold in well-known 
control function approaches. 
 
19 H-1( . ) could be written in long form as  H(X|W)
-1 ( . ). 
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where Xu = U(0, 1), U(a, b) denotes a random variable that is uniformly distributed on the 
interval (a, b) and H( ) is the conditional cdf of X given W.  A vector of IV satisfying the 
regular IV assumptions completes identification of (33) and the relevant AIE in (32) which 
is a version of (1). These assumptions are reviewed below. 
IV1. Exclusion Restriction 
  Y
X*
 ⊥ W+|V        (36a) 
where ⊥ indicates statistical independence. IV1 states that Y
X*
 and W+ are independent 
conditional on V implying that W+ is excluded from the conditional pdf of Y
X*
|V. In terms 
of the relevant DGP, (36a) amounts to20 
 f(Y | X, W, Xu; π) =  f(Y | X, Xo, Xu; π) 
where f(. ; .) is a known conditional pdf and π is a parameter vector. For a minimally 
parametric specification of the 2PM, the relevant version of IV1 is 
 E[Y | X,W, Xu]= E[Y | X, Xo, Xu]= μ(Y, X, Xo, Xu; β)  (36b) 




20 The equality could be written in long form as f(Y | X, W, Xu)( . ; .) =  f(Y | X,  Xo, Xu)( . ; .) 
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IV2. Independence Between the Instrument and the Potential Value of the Endogenous 
Variable (Random assignment) 
 XW+ ⊥ W
+|Xo        (37a) 
This assumption states that the identifying instrument W+  and XW+  are conditionally 
independent given Xo.  XW+ denotes a random variable representing the level of X that 
corresponds to an exogenously determined level of W+.  In the econometric literature on 
treatment effects, this IV assumption is called the random assignment to highlight the fact 
that units take on values of W+ independent of unobservable characteristics that determine 
the observed version of X i.e., X. Alternatively, (37a) can be stated as Xu ⊥ W
+|Xo. IV1 
and IV2 imply that W+ affects Y only indirectly through X. For consistent estimation of 
the conditional mean, a weaker version of (37a) given below is sufficient. 
 E[Xu|W
+] = 0       (37b) 
IV3. Strength of the Instrument 
 Conditional on Xo, variation in W
+ should generate variation in X. In other words, 
COV(X, W+) ≠ 0 where COV(a, b) denote the covariance between a and b. Given the 
specification for X in (34) and assumption IV2, it is clear that variation in W+ generates an 
exogenous variation in X for a given value of Xo. Assumptions IV1- IV3 are sufficient to 
identify homogenous effect parameter i.e., where the effect of the X is constant for each 
unit in the population. 
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IV4. Monotonicity of the Instrument and the Unobservable in the Specification for X 
 Monotonicity assumption is especially important to identify an EP where the effect 
of the X is allowed to vary across units based on their Xu which can be thought to represent 
types of units. In such heterogenous effect models, except for the case where the causal 
variable of interest is binary and the instrument is discrete, monotonicity of X in the 
instrument W+ and the unobservable scalar Xu are not equivalent (Imbens, 2007). Thus, I 
discuss each separately below. 
IV4.1 Strict Monotonicity in the Instrument 
 If H-1(Xu = xu, Xo,W
+ = w; δ) > H-1(Xu = xu, Xo, W
+ = w'; δ)  
for some (Xu = xu, W
+=w, W+=w'), then 
H-1(Xu = xu
' , Xo,W
+ = w; δ) > H-1(Xu = xu
' , Xo,W
+= w'; δ) for all possible realizations of 
Xu. In other words, the instrument should move the value of X (also called the level of 
treatment) in the same direction for all types of units. 
IV4.2 Strict Monotonicity in the Unobservable 
 If H-1(Xu = xu, Xo, W
+ = w; δ) > H-1(Xu = xu
' , Xo, W
+= w; δ)  
for some (Xu = xu, Xu = xu
′ , W+=w), then  
H-1(Xu = xu, Xo,W
+ =w'; δ) > H-1(Xu = xu
′ , Xo,W
+=w'; δ) for all W+ = w' . Alternatively 
stated, strict monotonicity in Xu indicates that as the value units take in (0, 1) increases, 
their corresponding level of X must move in the same direction for all possible realizations 
of W+.  
 A sufficient condition for strict monotonicity of X in W+ and Xu is that H
-1( . ) is 
either strictly increasing or strictly decreasing function in W+ and Xu , respectively. By 
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construction, the proposed GCF approach satisfies IV4.2 because once known fully 
parametric model is specified for X, by the inverse transform theorem, Xu, the cdf of X, is 
necessarily strictly monotonic. Therefore, if one can argue that assumption IV4.1 is 
satisfied, in addition to IV1-IV3, the GCF induces CIND between X and Y
X*
 and hence 
identifies heterogenous effects. 
THEOREM: Given the expression in (34) and under assumptions IV1-IV4 above, 
conditional on V = [X
o
  Xu = H(X, W; δ)], X and YX*  are independent. 
Proof 
By IV1-IV2 we have 
 Y
X*
 ⊥ (W+| Xo, Xu) 
Given (34) and IV4.2, (35) holds where H(X, W; δ) is one-to-one function of Xu. 
⟹      Y
X*
 ⊥ (W+| Xo, Xu = H(X, W; δ))  
IV2-IV3 (the variation in W+ generates an exogenous variation in X that is independent of 
Xu) and (34) implies 
 Y
X*
 ⊥ (H-1(Xu, W; δ )|Xo, Xu = H(X, W; δ)) 
⟹ Y
X*
 ⊥ (X|Xo, Xu= H(X, W; δ)) □ 
Theorem 1 establishes that the proposed approach satisfies the CIND needed to identify 
the conditional mean in (31) and the corresponding AIE in (32). Because Xu entails full 
information about the residual, I call the proposed approach as the generalized control 
function (GCF) approach.21  
 
21 The GCF identification argument here is closely related to those put forth for less 
parametric cases by Imbens and Newey (2002, 2009), Newey, Powell and Vella (1989) 
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 Following the result from theorem 1, we can substitute H(X,W; δ) for Xu in (33) to 
obtain the relevant DGP as 
 pdf(Y|X, Xo, H(X,W; δ)) = f(Y|X, W, H(X,W; δ); π)  
  = [ G
(ζEM
*




, X, Xo, H(X,W; δ); τEM) ]
I(Y = 0)
 
  × [(1 −  G
(ζEM
*














, Xo, H(X,W; δ))




| Xo, H(X,W; δ))
IM
(ζIM, X, Xo, H(X,W; δ); τIM)
]
1 ‒ I(Y= 0)
  
          (38) 
The corresponding conditional mean is  
 E[Y | X,W, H(X,W; δ)] = (1 ‒ G
(ζEM
*














, Xo, H(X,W; δ))







| Xo, H(X,W; δ))
IM
(ζIM, X, Xo, H(X,W; δ); τIM)
   
          (39) 
Evaluating (39) at  Xpre+∆ and  Xpre  and finding the difference and averaging over the 
entire Xo and H(X,W; δ) yields a version of the AIE in (32). The deep parameters of the 
model in (38) and the AIE based on (39) can be estimated by a two-stage GCF approach 
(more detail later). We first discuss in the next section a more efficient approach to 
estimating these deep parameters. 
 
and Heckman and Robb (1986). It is also related to the fully parametric case in Terza 
(2009) where the X is assumed to be binary. 
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4.3 Full Information Maximum Likelihood Estimation of the Deep Parameters 
 A Full Information Maximum Likelihood (FIML) model for the 2PM is constructed 
based on the joint pdf of Y and X conditional on W and deep parameter vectors. The FIML 
model has the attractive that it implies a FIML estimation that provides asymptotically 
efficient estimates of the vector of deep parameters. We write a generic FIML model as 




since Xu is unit uniform, we have  
 = ∫ f(Y, X, Xu|W)(Y, X, W, Xu; τ, δ)dXu
1
0
   
Further simplifying yields 
 = ∫ f(Y|X, Xu, W)(Y, X, W, Xu; τ, δ)×g(X, Xu|W)
(X, W, Xu; δ)dXu
1
0
   
where g
(X, Xu|W)
(Y, X, W, Xu; δ) is the joint pdf of X and Xu conditional on W and a vector 
of parameter δ. The GCF implies that Xu is unit uniform and the variation in X due to 
variation in W is independent of Xu. Thus, 
 g
(X, Xu|W)




(X, W, Xu; δ) is the pdf of X conditional on Xu, W and the parameter vector 
δ; g
(Xu)
(Xu) is the pdf of the unit-uniform random variable Xu which equals 1. Therefore, 
the joint pdf of Y and X conditional on W and deep parameter vectors is   
 f(Y, X|Xu, W)(Y, X, Xo,Xu; τ, δ) = f(Y|X, Xu, W)(Y, X, W, Xu; τ, δ)×g(X|W)(X, W, Xu; δ) 
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Substituting Xu = H(X,W; δ) from (35), the joint pdf upon which the FIML model is based 
is given as 
 f(Y, X|Xu, W)(Y, X, Xo,Xu; τ, δ) = f(Y|X, Xu, W)(Y, X, W, H(X,W; δ) ; τ) 
     ×g
(X|W)
(X, W, H(X,W; δ))    
          (40) 
The conditional pdf in (40) is a FIML model for the FP2PM with GCF that affords a FIML 
estimation. I call the MLE of the deep parameter vectors (τ, δ) based on the log-likelihood 
function of the pdf in (40) as the Generalized Control Function-Full Information Maximum 
Likelihood (GCF-FIML) estimator. 
 To obtain the specific GCF-FIML estimator of the deep parameter vectors, specific 
functional forms for the EM and IM need to be specified. In traditional 2PM framework, 
different functional forms are specified for the EM and the IM components. For instance, 
for modeling a continuous outcome in 2PM context, a logit EM and a gamma IM can be 
specified (Biener et al, 2020). However, as demonstrated in Hao and Terza (2018), such 
difference in structure is not needed. In a generic FP2PM, Hao and Terza (2018) 
analytically and via simulation show the robustness of maintaining NSD assumption for 
the EM and IM. In the context of the conditional pdf in (38) and a specific version of the 













| Xo, H(X,W; δ))
IM
(Y,X, Xo, H(X,W; δ); τIM) . Specifying the FP2PM this 
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way allows a formulation of a statistical test for the null hypothesis that “no 2PM is needed” 
in a particular empirical context. Once NSD is maintained the only source of the systematic 
difference between the process that generates zero values and that which determines the 
strictly positive values comes from a difference in the deep parameter vectors for the two 
components of the 2PM. This parametric difference refers to the possibility that the 
parameter vectors τEM and  τIM in (38) are different. In the next subsection, a functional 
form is specified for the 2PM with NSD between the EM and the IM components. To 
appease any concern with misspecification of the fully parametric model, I assume a very 
flexible distribution for the EM and IM components of the 2PM as well as for the 
endogenous variable.  
4.3.1 Specification of the Conditional Density with NSD 
 I specified a GG distribution for both the EM and IM components as well as for the 
endogenous variable.  GG is parametrically very flexible distribution that subsumes several 
known distributions such as the Weibull, exponential, the standard gamma, and so on. The 
GG has been discussed and is being increasingly utilized in health economics and health 
service research methodology (Manning et al. 2005, Liu et al. 2010, Smith et al, 2015). The 
GG is particularly useful to fit continuous outcomes in empirical health economics (e.g 
health care cost) that are characterized by nonnegative values with long tail. Such a flexible 
distributional assumption appeases concern for misspecification of the functional form.22  
 
22 The generalized linear model (GLM) is extensively employed modeling framework to 
analyze the IM component in continuous 2PM (e.g Biener et al. 2020; Cawley et al. 2015; 
Chang and Mayerhoefer, 2016) Despite the fact that choosing an appropriate link and 
variance functions are the key for the performance of GLM estimators, no theoretically 
well-grounded procedure is available to guide these choices.  Some tests such as the Park 
Test (Pregbon, 1980) and a modified Hosemer-Lemeshow test (Hosemer and Lemeshow, 
1995) can be used to diagnose but not to fix misspecification of the link function. The 
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 Accordingly, the specific version of the conditional joint pdf in (40) for the 2PM 
with a GG distributional assumption for both the outcome and the continuous endogenous 
variable is  
 f(Y, X|W, H(X,W; δ))(Y, X, W, H(X,W; δ); π) 
    = [GG
(ζEM
+






+ Xoβo1+ GG(X | W)(X, W; δ)βu1, σEM,κEM)]
I(Y = 0)
    
× [(1 ‒ GG
(ζEM
+












 | X, W, H(X,W; δ))




 | X, W, H(X,W; δ))
IM
(ζIM, XβX2+Xoβo2+ GG(X | W)(X, W; δ)βu2; σIM, κIM)
]
1 ‒ I(Y = 0)
 
 ×gg
(X | W)(X, Wδ ; σδ, κδ)       
          (41) 
where π' = [δ'     β
1
'
     σEM     κEM     β2
'
     σIM     κIM]  is the deep parameter vector such 
that δ' = [δW     σδ     κδ] ; β1
' = [β
X1
     β
o1






     β
o2




 is the 
component of the DGP that may be observed as a strictly positive outcome depending on 




(A, b, c, d)  and gg
(A|B )
XM (A, b, c, d) are the cdf and pdf, respectively, 
of a GG random variable A given B for the XM component of the 2PM with location 
 
modified Park Test suggested by Manning and Mullahy (2001) might be used to specify 
the variance function conditional on appropriately specified link function but this test relies 




parameter b and shape parameters c and d. GG(X | W)(X, W; δ) and gg(X | W)(X, W; δ) are 
also the cdf and pdf, respectively, of a GG random variate X given W with parameter vector 
δ. The specific expression for the pdf and cdf of the GG are given in (21) and (23), 
respectively. 
 The shape parameters σEM and κEM are not, however, identified. Nevertheless, the 










+ Xoβo1+ GG(X,W; δ)βu1, σEM,κEM) 








; ν)    
          (42) 






























ln(νEM) ]. Combining (41) and (42), we obtain an approximation for the 
conditional joint pdf in (41) as 
 f(Y, X|W, H(X,W; δ))




















; ν)  
 
23 See Hao and Terza (2018) for a simulation evidence on the consistency of an estimator 







|X, W, H(X,W; δ) )




|X, W, H(X,W; δ))
IM
(ζIM, XβX2+ Xoβo2+ GG(X, W; δ)βu2;  σIM,κIM)
]
1 ‒ I(Y = 0)
 
  × gg
(X | W)(X, Wδ ; σδ, κδ)       
          (43)  
The vector of deep parameters π can be estimated by maximizing the following log-
likelihood function based on (43). 
 L(π|Y, X, W)= ∑ ln (f(Y, X|W, H(X,W; δ))
~ (Yi, Xi, Wi, GG(Xi,Wi; δ); π) )
n
i=1    
          (44) 
where, Yi, Xi, and Wi are the values of Y, X, and W observed for the ith individual in the 
sample (i = 1, 2, …, n). ζ
IM
 is estimated by the minimum order statistics i.e., the smallest 
non-zero value in the sample. An estimator of the AIE in (32) can then be derived by 
plugging in the deep parameter estimates of the above log-likelihood function and the 
minimum order statistics ζ
IM
 for the corresponding deep parameter vectors and replacing 
the expectation operators by summation notation. Hence, the AIE estimator is 

















1 ‒ GGIM(ζ̂IM, (Xi
pre
 + ∆i)β̂X2+Xoiβ̂o2+ GG(Xi,Wi; δ̂)β̂u2; σ̂IM,κ̂IM)
] 


















1 ‒ GGIM(ζ̂IM, Xi
pre
β̂X2+Xoiβ̂o2+ GG(Xi,Wi; δ̂)β̂u2; σ̂IM, κ̂IM)
]   
          (45) 
where π̂' = [δ̂     β̂
X1
p
     β̂
o1
p '
     β̂
u1
p
     β̂
X2
     β̂
o2
p '
     β̂
u2
p
     σ̂IM     κ̂IM] is a vector of the MLE 
estimates, ζ̂
IM
 and Ymax  are the minimum and maximum values of Y in the sample, 
respectively. For notational clarity, the subscripts in the gg and GG are suppressed. I call 
the AIE estimator in (45) the GCF-FIML based AIE estimator. The asymptotic standard 
errors of the MLE for the deep parameter in (45) can be obtained using the approach in 
Terza (2017). 
4.3.2 Hypothesis Testing 
 The proposed approach affords easy-to-implement procedures for testing two 
crucial hypotheses in the context of the FP2PM framework where the X is a continuous 
endogenous variable. These are testing procedures for the null hypotheses that “no 2PM is 
needed” and “the causal variable of interest is exogenous”. Below I discuss each of them. 
4.3.2.1 Testing the “No 2PM is needed” Null Hypothesis 
 As mentioned earlier, the main features of the 2PM is that it allows the process 
governing the zero outcomes to systematically differ from that which determines strictly 
positive outcomes. Practically, the choice regarding the 2PM as the analytical framework 
in a given empirical context is guided by the presence of excess zeros and/or a theoretical 
ground. For example, in the health utilization research, analysts put forward two 
justifications for using the 2PM. First, a substantial proportion of individuals in a given 
sample have zero health care expenditure. Second, the decision to spend the first dollar is 
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determined entirely by the patient while subsequent decisions are largely influenced by 
physicians (Pohlmeier and Ulrich, 1995). Testing statistically whether the 2PM is needed 
can, therefore, facilitate the choice of parsimonious model while providing insight into 
important theoretical predictions. 
 I developed a “no 2PM is needed” hypothesis testing procedure by utilizing the 
NSD assumption and by arguing that a certain reduction of unidentified ancillary 












| Xo, Xu )
IM
(Y,X, Xo, H(X,W; δ); τIM) 
have same functional forms. In our case, the underlying EM latent variable and the 
observed IM component for those units with strictly positive outcome are assumed to have 
a GG distribution. Next, I argue that the following reduction of the version of the model 
given in (41) is admissible.  
 f(Y, X|W, H(X,W; δ))(Y, X, W, H(X,W; δ); π) 
= [








+ Xoβo1+ GG(X | W)(X, W; δ)βu1 ;σ, κ)]
I(Y = 0)
 
× [(1 ‒ GG
(ζEM
+










 | X, W, GG(X | W)(X,W; δ))
IM (Y, Xβ
X2








+Xoβo2+ GG(X | W)(X, W; δ)βu2; σ, κ)
]
1 ‒ I(Y = 0)
 
 
24 See the discussion in Terza (1985) about admissible reduction. 
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   × gg
(X | W)(X, Wδ ; σδ, κδ)        
          (46) 
In other words, (46) implies that the following reduction of the model is admissible (i.e., it 
reduces the number of parameters to be estimated but does not distort the probability 
densities as assigned by the DGP).   
 σEM = σIM = σ  










As the basis for this argument let 
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EM
+
 is a GG variate with parameters Xβ
X1
+ Xoβo1+ GG(X | W)(X, W; δ)βu1 , 









is a standard gamma variate with shape parameter ν (Crooks, 2010). We seek a 
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 is the same as ‒pβ
o1
 with its constant term 
shifted by p ln(ζ
EM













+ Xoβo1+ GG(X,W; δ)βu1, σEM, κEM) 





+ GG(X, W; δ)β
u1
o ); ν).   
          (47)  
This discussion clearly demonstrates the fact that the values of ζ
EM







  and  β
u1
o
 so that they are not identified.  Their values are, in this sense, arbitrary.  
This, of course, means that 
 ζ
EM
 =  ζ
IM
 = ζ   
 σEM  = σIM = σ 
constitutes an admissible reduction. The argument for the admissibility of the reduction 
 κEM  = κIM = κ 







  and  β
u1
o
. In a simulation analysis, I demonstrated that fixing the value of κEM, 
and hence ν, at any arbitrary level does not affect the consistency of an AIE estimator, 
which is based on a likelihood function that is constructed from the conditional pdf in 
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(47).25 Thus, the “no 2PM model is needed” null amounts to setting the β parameters of the 
EM and IM component equal. i.e., 
  Ho: βi1= βi2= β   
  H1: Ho is not true 
for i = 1,2,…K where K is the number of deep parameter coefficients. Thus, the relevant 
joint pdf conditional on Xo, and H(.) under the null becomes  
   f(Y, X|W, H(X,W; δ))
~ (Y, X, W, GG(X,W; δ); π)     
=  [SG(exp(p ln(ζ) + ln(ν) + X(‒pβ
X
) + Xo(‒pβo)+ GG(X, W; δ)(‒pβu); ν) ]
I(Y = 0)
 
× [(1 − SG(exp(p ln(ζ) + ln(ν) + X(‒pβ
X1
) + Xo(‒pβo1)+ GG(X, W; δ)(‒pβu1); ν)  





|X, W, H(X,W; δ) )




|X, W, H(X,W; δ))
IM
(ζ, XβX+ Xoβo+ GG(X, W; δ)βu; σ, κ)
]
1 ‒ I(Y = 0)
    
      × gg
(X | W)(X, Wδ ; σδ, κδ)        
          (48)  
This is a version of the joint pdf in (43) with the “no 2PM is needed” null imposed. The 
corresponding approximate log-likelihood function is 
 LHo(λ | Y, X, W) = ∑ ln [f(Yi, Xi, Wi, GG(Xi,Wi; δ); λ)]
n
i=1    
 
25 See appendix II for a detail discussion of the simulation design and the results. 
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LHo(. | .) denote the log-likelihood function to be maximized under the null. Given the 
unrestricted log-likelihood in (44), the likelihood ratio (LR) statistics  
 LR = ‒2×[L(π|Y, X, W) ‒ LHo(λ|Y, X, W) ]     (49) 
has a χ
(Kπ ‒ Kλ)
2  where χ
(Ka ‒ Kb)
2  denotes the chi-square distribution with the degrees of 
freedom equal to the difference between the number of parameters in vectors a and b. 
4.3.2.2 Testing for Exogeneity 
 In general, control function (CF) approaches address endogeneity by constructing 
a function that when conditioned on is supposedly induce CIND between the observed 
causal variable of interest and the potential outcomes. CF approaches naturally affords a 
simple procedure to test the null hypothesis that the causal variable of interest is exogenous. 
In particular, a t-test on the coefficient of the control function can be conducted to test if 
there is an evidence for endogeneity of the X. The deep parameters in our case are, however, 
more than one. In particular, under the GG specification the null (Ho) and the alternative 
(H1) hypotheses for testing exogeneity of the X are  
 Ho: β1u= 0 and β2u=0        
 H1: Ho is not true 
Similar to the test for “no 2PM is needed”, the log-likelihood function under the null is a 
version of (48) with the restriction of the Ho . Because such log-likelihood is a nested 
version of the log-likelihood in (44), a likelihood ratio test statistic can be obtained by 
multiplying the difference in the log-likelihood values under H1  and Ho  by 2 which is 
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distributed as χ(2)
2 . Unlike two-step estimation protocols, because the proposed GCF-FIML 
is a one-step FIML estimator, it provides correct standard errors regardless of the decision 
about the above null hypothesis.  
4.4 Simulation Study: Validating the Consistency of the GCF-FIML Based AIE Estimator 
and Comparing its Performance with Alternative Approaches 
 In this section, I demonstrate the implementation of the GCF approach, validate the 
consistency of the GCF-FIML based AIE estimator in (45) for a version of the AIE in (32) 
and compare its performance to four alternative estimators: namely, the two-stage residual 
inclusion (2SRI), the two-stage least square (2SLS), the two-stage predictor substitution 
(2SPS) and the two-stage Generalized Control Function (2SGCF) estimator. I first present 
the data generator for the true model in (38). Then the sampling design for generating a 
pseudo sample is presented. This will be followed by the analytical detail of the four 
alternative estimators. At the end of this section, the results of the simulation will be 
discussed. 
4.4.1 The Data Generator 
 In order to conduct the simulation study, first, I develop Stata/Mata code for the 
true model in (41). The protocol for the simulator is as follows: 
 1) Choose the elements for the parameter vector 
 π' = [δ'   σδ     κδ     β1
'
     σEM     κEM     β2
'
     σIM     κIM]   and the unobserved 






 2) Generate a sample of simulated data for Xo  and W
+ ; each assumed to be 
uniformly distributed with mean and variances chosen as part of the sampling design. 
 3) Generate a sample of simulated data for X from a GG distribution as 






, σX, κX)   




pX      (50) 
with a specified parameter vector δ' = [δW
'




   δXo    δcon] , the 
coefficient vector for the linear index δW that represents the location parameter, and σX 
and  κX denote the shape parameters of the distribution. δcon is an intercept term of the 





















 4) Recover the values for Xu by calculating the cdf of X i.e.,   




, σX, κX)    (51) 
 5) Generate a sample of outcomes at the EM (Y = 0 or not) i.e., 










+Xoβo1+ GG(X | W)(X, W; δ)βu1, σEM, κEM) > U  
          (52) 
where U is a unit uniform random variable.  
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 6) Complete the construction of the sample by simulating the IM values for the 
subpopulation of units for whom the EM = 1 . These values need to be drawn from 
appropriately specified truncated distribution. Below I extend the derivation of the data 
generator for the truncated GG distribution discussed in Hao and Terza (2018) for the case 
where the X is endogenous. 
 A version of the cdf of a GG variate in (23) can be written in an important way as 
    SG(ν, ( ζ a⁄ )
p
)  if p > 0 
 GG(ζ, Xβ, σ, κ) =        (53)  
    1 ‒  SG(ν, ( ζ a⁄ )
p
) if p < 0 














 and ζ is unobserved parametric 
threshold. (52) implies that for p > 0,  
 GG
‒1 
(P, Xβ, σ, κ) = a× [SG‒1(P ; ν,1)]
1
p    
where P is a value in the unit interval and GG‒1 (P; c, d, e) is the inverse cdf of a GG 
variate with parameters c, d and e evaluated at P. For a truncated GG random variable, a 















+Xoβo2+ GG(X,W; δ)βu2, σIM,κIM)
 




(Y; c, d, e, ζ) is the cdf of a truncated GG for Y with parameters c, d and e 
truncated at ζ. Now (54) implies that I can generate a truncated GG random variable y 
based on   




+Xoβo2+ GG(X,W; δ)βu2, σIM,κIM) ]×U(0,1) 
 = GG(Y ≥ζIM)(Y; XβX2+Xoβo2+ GG(X,W; δ)βu2, σIM, κIM)  (55) 
We want to use GG
‒1 
(Y; c, d, e)  not GG(Y ≥ζIM)
‒1
(Y; c, d, e)  to generate the desired 





+Xoβo2+ GG(X,W; δ)βu2, σIM, κIM) gives 









+Xoβo2+ GG(X,W; δ)βu2, σIM, κIM) 
 = GG(y; Xβ
X2
+Xoβo2+ GG(X,W; δ)βu2, σIM, κIM)   (56) 
where the right side is the sum of GG(Y ≥ζIM)
(Y; Xβ
X2





+Xoβo2+ GG(X,W; δ)βu2, σIM, κIM). From (56), it follows that 
 y = GG‒1 (A; Xβ
X2
+Xoβo2+ GG(X,W; δ)βu2, σIM, κIM)  (57) 
where  









+Xoβo2+ GG(X,W; δ)βu2, σIM, κIM) 
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To complete the data generation,  
 5a) Generate U(0,1) 
 5b) Obtain the linear index Xβ
X2
+Xoβo2+ GG(X,W; δ)βu2 based on 1) to 4) above. 
 5c) Plug the values from 5a, 5b and the parameter values  σIM and κIM into (56) to 
get the desired pseudo random variable y. 
4.4.2 The Sampling Design 
 To validate the consistency of the GCF-FIML based AIE estimator for a version of 
the AIE in (32) and to compare its performance with the alternative estimators such as the 
2SRI, 2SLS, 2SPS and 2SGCF, the following sample design is considered.  





   δXo    δcon] = [0.75     ‒0.5     ‒1] 
for the linear index coefficients. The means and variances of Xo  and W
+  are set to be 
E[X
o
] = 1, E[W+] = 1, Var[X
o
] = 0.45 and Var[W
+
] = 1. I also set values for the shape 
parameters as σX = 0.51 and κX = 0.25. 
 2) For generating the values at the EM, I set the values for the linear index 
coefficients, the shape parameters and the parametric threshold for (52) as follows 
 [β
X1
     β
u1
     β
o1





   β
cons1
] are the coefficients for Xo and the intercept, respectively.  
 σEM = 0.5    
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 κEM = 1 
  ζ
EM
 = 0.75 
Note that σEM, κEM and ζEM are not identified in 2PM. 




     β
u2
     β
o2





   β
cons2
] are the coefficients for Xo and the intercept, respectively.  
 σIM  = 1.5    
 κIM =  1.5 
  ζ
IM
 = 2 
 4) For testing the consistency of the AIE based on the proposed approach, samples 
of increasing size are generated based on the above sampling design. In particular, the 
samples are generated with the following sizes. 
 n = 1,000    
 n = 5,000     
 n = 15,000         
 n = 25,000   
 n = 50,000   
 n = 100,000   
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 n = 250,000   
 n = 500,000  
4.4.3 Alternative Approaches to Correcting Endogeneity in the 2PM 
 In sections 4.2 and 4.3 I presented detailed discussion on the proposed GCF 
identification approach and the implied GCF-FIML estimator for correcting endogeneity 
in a FP2PM framework from the potential outcomes perspective. In this sub-section, I 
layout four alternative approaches for correcting endogeneity mentioned at the beginning 
of section 4.4. These approaches except the 2SGCF are employed in empirical research in 
the context of the 2PM with continuous outcome and continuous endogenous variable. Like 
the GCF-FIML approach, all of these approaches use an IV to identify CI parameters. To 
facilitate comparison with the proposed approach, these alternative approaches are cast 
within the GPOF. Thus, I commence the discussion on this sub-section by assuming that 
the conditional pdf in (30) holds.  
4.4.3.1 The Two-Stage Residual Inclusion Approach26 
 This approach requires only specification of the conditional mean function for the 
outcome and endogenous variables. To facilitate comparison with the proposed approach, 
I instead focus on a 2SRI approach based on a FP2PM. Such approach helps provide a 
correct specification for the conditional mean and also improves the efficiency of estimated 
parameters.  Terza, Basu and Rathouz (2008) suggested the following auxiliary regression 
for the endogenous variable. 
 
26 The 2SRI estimation approach, popularized by Terza, Basu and Rathouz [TBR] (2008), 
is a control function approach for estimating causal effects in a general additive non-linear 
triangular model in which nonlinear models are specified both for the outcome and 
endogenous variables such that the former does not causally affect the later. 
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 X = r(W; δ) + Xu       (58) 
where r( . ) is a known conditional mean function. Extending the assumption of a GG 
distribution for the X to this context, we have       
 r(W; δ) = exp {Wξ + (σ/κ) × ln(κ2) + ln[Γ( 1
κ2
⁄ ) + (σ/κ)] ‒ ln[Γ( 1
κ2
⁄ )] }  
          (59) 
where the right-hand side is an expression for the conditional mean of a GG variate X. 
Although δ' = [ξ'     σ   κ] can be consistently estimated by using non-linear least square 
(NLS), by taking advantage of a known distributional assumption for X, a more efficient 
estimate for the parameter vector δ can be obtained via MLE. Invoking the standard IV 
conditions IV2-IV3 (in addition to the IV1 that ensures exclusion of W+ from the specified 
model for the outcome), TBR argue that the following raw residual can serve as a control 
function that induces CIND between X and Y
X*
. 
 X̂u = X ‒ r(W; δ̂)       (60) 
By plugging (60) for Xu  into a version of (41) where the standard gamma admissible 
reduction replaces the GG in the EM, the relevant conditional pdf is given as 
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    σIM
2SRI]  for the IM can then be estimated by maximizing the 
log-likelihood function based on (61). 27  The corresponding AIE estimator whose 
consistency for a version of the AIE in (32) will be evaluated is 28  

















































































]  (62) 
 
27 The 2SRI model does not require a fully parametric specification for the outcome. In 
fact, by plugging (53) into a conditional mean function for the outcome, TBR show that 
the 2SRI is the best predictor in the sense of minimizing mean square prediction error. 
28  Corresponding to the result shown in the admissible reduction in (47), β
X1




























The consistency of the above 2SRI estimators for the AIE depends on whether or not the 
specified raw residual based on the auxiliary regression function for Xu  in (60) is correct. 
4.4.3.2 The Two-Stage Least Squares Approach 
 The 2SLS approach is one of the most widely used approach to estimate causal 
effects when the causal variable of interest is endogenous. Its applicability for 2PM is, 
however, limited because it ignores the nonlinearity in the EM and IM components of the 
2PM that is often inherent in many empirical settings. Some applied research, however, 
still use it mainly for its simplicity in estimation and interpretation. Under the 2SLS, the 
auxiliary regression model for X is specified as 
 X = δW + Xu        (63) 
which is typically estimated using the OLS approach. By IV3 and the minimally parametric 
version of IV2, the above model generates a variation in X that is independent of Y
X*
, 
making  Xu redundant in the conditional mean function for the outcome. This exogenous 
variation in X is obtained from the predicted values based on the OLS estimates of δ in 
(63). These predicted value are given as 
 X̂ = δ̂W         (64) 
On the other hand, the minimally parametric version of IV1 ensures that W+ is excluded 
from the linear conditional mean function specified under 2SLS. This implies that the 
conditional mean is given by 
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 E[Y | X, Xo, Xu] =  E[Y |X, W]  
 = [αX1X̂ + αo1Xo]×[αX2X̂ + αo2Xo]     (65) 
where P(Y > 0|X, W) = [αX1(δ̂W) + αo1Xo]  and E[Y | 𝑌 > 0, X, W] = [αX2(δ̂W) + 
αo2Xo] are the conditional mean functions for the EM and IM components of the 2PM, 
respectively. The 2SLS AIE estimator for a version of (32) is, thus,  
 AIE(∆)  = ∑ [[(X̂i
pre
 + ∆i)α̂X1+ α̂o1Xoi]×[(X̂i
pre
 + ∆i)α̂X2 + α̂o2Xo]]
n
i=1    






i=1    (66) 
When the object of interest is causal estimation, Angrist (2001) argues that linear 
probability model for the EM component can often provide a good approximation to the 
conditional probability whether the X is binary, count or continuous. Black et al (2018), 
for instance, specified a linear IV model for the EM component of the 2PM to estimate 
health care cost of childhood obesity and find identical estimate as logit estimates. They 
also argue in favor of using 2SLS for the IM component of the 2PM because log health 
cost is approximately normally distributed. Linear approximation to the IM component is, 
however, problematic due to skewness and heavy tail that typically characterize many of 
the semi-continuous outcomes cast in a 2PM context. Although transformation of the 
continuous component of the IM mitigates these data problems, the issues involved in the 




4.4.3.3 The Two-Stage Predictor Substitution Approach 
 The 2SPS is a rote extension of the 2SLS approach. The argument for the first stage 
regression is the same as the 2SLS approach where the auxiliary regression for X is 
specified as in (63) and the corresponding predicted values are obtained as in (64). These 
predicted values are then substituted in the second stage in a specified nonlinear conditional 
mean function. Like the 2SRI approach, I specify a FP2PM to evaluate the consistency of 
an AIE estimator for a version of (32) based on the 2SPS approach. The protocol for 
estimating an AIE under 2SPS approach is as follows: 
First stage 
Obtain the predicted values from a first stage linear regression of X on the vector of controls 
and instruments W like the one in (64).  
Second Stage 
Note that like the 2SLS, the 2SPS approach assumes that under the minimally parametric 
version of IV1-IV2 and IV3, the Xu is redundant. Therefore, the relevant conditional pdf 
can be obtained by substituting (64) for X in a version of (33) where Xu  is excluded. 
Assuming a GG for both the EM and IM components of the 2PM and using the standard 
gamma admissible reduction for the EM component, we have the relevant conditional pdf 
upon which the second stage estimation is based as 


















































          (67) 
The deep parameters of the above model can be estimated by maximizing a log-likelihood 
function based on (67) above. The corresponding 2SPS AIE estimator for a version of (32) 
is 29  









































































29  Corresponding to the result shown in the admissible reduction in (47), β
X1




























4.4.3.4 The Two-Stage Generalized Control Function Estimator 
 The 2GCF is a two-stage estimator of the conditional pdf given in (38). It is an 
estimator of the deep parameter vector in (38) that is computationally less demanding yet 
less efficient than the GCF-FIML estimator, a one-step MLE estimator based on the joint 
pdf in (43). The procedure for estimating the deep parameter vector in (38) under the 
2SGCF approach is as follows: 
First stage 
Estimate the deep parameters of the fully parametric model for the endogenous variable 
and obtain its cdf based on the estimated parameters. In the specific case we consider here, 
the first stage involves estimating δ, the GG parameter vector for X, and obtain the cdf of 
X as X̂ui = GG(Xi,Wi; δ̂).  
Second Stage 
Substitute as X̂ui = GG(Xi,Wi; δ̂) into the conditional pdf in (38) and estimate its deep 
parameters by maximizing the implied log-likelihood function. Under the conditions 
outlined in theorem 1, the MLE obtained in this way is necessarily consistent. Although 
the 2SGCF is computationally less burdensome, it leads to unnecessary efficiency loss as 
it ignores relevant information entailed in the joint pdf of Y and X. The 2SGCF approach 
is also amenable to conduct the two hypotheses discussed in sections 4.3.2.1 and 4.3.2.2. 
4.4.4 Simulation Results 
 As discussed above the true model outlined in section 4.4.1 is based on (38). I 
generated a super sample of n =1,500,000 to compute the true AIE. The proposed GCF-
FIML, 2SGCF and the three alternative AIE estimators are applied on each of the samples 
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generated. The absolute percentage bias (APB) for each AIE estimate is then computed 
using the formula in (26).  
 Table 6 presents the result of the simulation. The true AIE based on the sampling 
design is 2.1449. The AIE estimates from six different estimators are presented in 
successive columns. These estimators are the GCF-FIML, 2SGCF, 2SRI, 2SPS, 2SLS and 
the Full Information Maximum Likelihood Estimator with exogenous causal variable 
(FIML-EXOG). The last estimator is based on a FIML model that ignores the endogeneity 
of the causal variable. The APB of the GCF-FIML and 2SGCF based AIE estimates are 
almost the same for most of the sample sizes. The estimated AIEs from these two estimators 
have small APB that gets close to 0% as the sample size of the simulated data increases. 
On the other hand, the 2SLS based AIE estimates have an APB of around 30% even for 
very large sample sizes. The 2SPS AIE estimates are also biased with an APB of around 
25% for very large samples.30 This APB is comparable to the APB of the FIML estimator 
that ignores the endogeneity of the X. While the 2SRI based AIE estimator performs better 
than the 2SPS, 2SLS and FIML-EXOG based AIE estimators, the APB for its estimates 
hoovers around 10% even for very large sample sizes. 
 To examine how sensitive the estimates are to the amount of endogeneity and 







31 The resulting model based on this sample has much lower endogeneity and nonlinearity. 
As shown in table 7, the new true AIE computed based on a super sample of n =1,500,000 
 
30  Convergence was not achieved for sample sizes of n = 25,000 , n = 50,000  and 
n = 100,000. 
 
31 See the entire sampling design in appendix IV. 
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is 2.009. The table also presents the AIE estimates based on the six estimators outlined 
above using new samples of increasing size. Again, the GCF-FIML and 2SGCF based AIE 
estimators perform very well in terms of consistency as the APB of the estimates gets close 
to zero for large sample sizes. The 2SRI and 2SLS based AIE estimators perform well. The 
2SPS based AIE estimator, however, still has a substantial APB even for very large samples. 
In fact, in this particular sampling design, the 2SPS AIE estimator is even worse than the 
FIML-EXOG based AIE estimator that ignores endogeneity. The above results imply that 
the proposed GCF-FIML and the 2SGCF based AIE estimators are consistent for a version 
of the AIE in (32) and outperforms the alternative three estimators that are commonly used 
in the context of the 2PM.  
4.5 Application: The Medical Care Cost of Obesity in Youth in the US 
 Obesity rate among children in the US has more than quadrupled from 5% in 1971-
1974 to 20.5% in 2015-2016. (Anderson and Butcher, 2006; Ogden et al., 2012; Ogden et 
al., 2016; Hales et al., 2018). Obesity is linked to several chronic diseases such as diabetes, 
high blood pressure, asthma, depression, musculoskeletal diseases and cardiovascular 
diseases. A growing number of policies and programs are implemented to curb this 
alarming trend. To determine the optimal level of spending towards addressing obesity in 
children, it is imperative to have an accurate estimate of the effect of obesity on the 
healthcare system. Medical care expenditure is suitable for two-part modeling because a 
substantial proportion of youth has zero medical spending in a given year. For instance, 
31.9% of the youth in our sample have observed zero amount of medical expenditure. 
Pohlmeier and Ulrich (1995) also discussed theoretical grounds that justify two-part 
modeling of medical utilization.  
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 In this section, I illustrate the econometric models and methods discussed in this 
chapter to estimating the average incremental effect of a one-unit increase in BMI on the 
total medical care spending among the youth in the US. I also estimate the total medical 
care spending AIE of a hypothetical event that moves every youths’ BMI from an average 
normal to an average obese and severely obese BMI. The potential outcomes specification 
for the AIE is 
 AIE(∆) = E [(1 ‒ SG
(ζEM
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4.5.1 Identification of the AIE  
 Our discussion in section 4.2 made it clear that identification of (69) is predicated 
on the requirement that Xo  and Xu induce CIND between X and YX* . Because Xu is an 
essential unobservable confounder, the X is endogenous and completing the identification 
requires one to add structure to the conditional pdf that imply the AIE in (69). In the context 
of the empirical setting that I consider, BMI/obesity can be endogenous because of 
unobserved health behavior that determine both the observed BMI and the potential 
medical care spending. For instance, those youth with higher BMI may also have 
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unobserved health behavior that leads to higher medical care spending implying that one 
would overestimate the AIE without addressing endogeneity. On the other hand, youth 
from lower socioeconomic status households tend to have higher BMI and lower access to 
medical care. In this case, ignoring the endogeneity of BMI causes underestimation of the 
AIE. Thus, addressing the endogeneity of BMI is crucial to obtain causally interpretable 
AIE.  
 I follow Biener et al (2020) and use mothers’ BMI as an instrumental variable for 
child BMI. The validity of this instrument is discussed extensively in the literature.32 Given 
the IV, we have the GCF-FIML and 2SGCF estimators of the deep parameters of (44) and 
(38), respectively, based on which the AIE in (69) is estimated. For comparison, I also 
estimate (69) using the 2SRI, 2SLS and 2SPS estimators given in (62), (66) and (68) 
respectively. In addition, the FIML-EXOG based AIE estimator is applied to the data. The 
log-likelihood from the FIML-EXOG MLE is used to test the null hypothesis that X is 
exogenous. I also estimate a one-part version of the GCF-FIML model to test the null that 
“no 2PM is needed”. 
4.5.2 Data and Descriptive Statistics 
 The data source for the empirical application is the public use version of the 
Medical Expenditure Panel Survey (MEPS). The household component of the MEPS is a 
comprehensive, nationally representative data for US civilian population. Information for 
each member of a participant household is obtained through 5 rounds of survey over two 
years. The unique feature of MEPS is that information on medical expenditure is 
 
32 For discussion of Instrumental Variables approach in estimating the medical care cost 
of obesity, see Biener et al (2020); Cawley and Meyerhoefer (2012); Cawley et al (2015) 
and Chang and Meyerhoefer (2016). 
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supplemented by expenditure data directly collected from participants’ medical providers 
and pharmacies through the medical provider component. Like Biener et al (2020), I limit 
the sample to individuals aged 11-17 as data is missing for several variables for those 
younger than this age group. The constructed sample also excludes underweight children 
because the focus is on obesity. The data I use covers the period 2009-2015. Following 
Biener et al (2020), the total medical care spending is top coded at $50,000.  
  Beiner et al (2020) exclude children who live with stepmother as doing so 
minimizes the concern for weak instrument. The biological linkage information is, 
however, part of the restricted use MEPS data. Thus, I do not distinguish stepmothers’ BMI 
from biological mothers’ BMI. To the extent that considerable proportion of children in 
the sample live with stepmothers, the strength of mothers’ BMI as instrument of child’s 
BMI reduces. This is not a concern for our case because the main goal of the empirical 
application is to demonstrate the implementation of the proposed approach and compare 
the estimates for the targeted parameters to those obtained using alternative estimators. In 
fact, the fact that the 2SPS AIE closely matches that in Biener et al (2020) implies that the 
biological linkage information is unlikely to have substantial effect on estimated AIEs. 
 Table 8 presents the descriptive statistics of the data for the full sample and by 
mothers’ obesity status (34% of the sample have obese and severely obese mothers). The 
outcome variable at the EM is whether a child has any medical spending and, in the sample, 
only 68.1% have positive total medical care spending, suggesting that the 2PM may 
provide the right framework for this empirical setting. For those children with positive 
annual expenditure, the average total expenditure is $993.46 with no statistically significant 
difference by mothers’ obesity status.  
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 The average BMI for the full sample is 21.23 while for children with obese and 
non-obese mothers the corresponding averages are 22.8 and 20.4, respectively. Children’s 
weight is classified into severely obese, obese, overweight and normal weight using the 
gender-age-specific CDC growth rate. Among children with obese mothers, 33% of 
children are obese and severely obese and the corresponding rate among those with non-
obese mothers is 17.1%, suggesting a potential for high strength of the instrument. The 
sample statistics for many of the control variables indicate significant differences by 
mothers obesity status especially for the race, insurance and mother’s health status 
variables. Biener et al (2020) analyzed whether differences in many other controls exist 
within race/insurance category and found that within most of the groups these differences 
disappear. Table 9 presents the descriptive statistics for the full sample and by children’s 
obesity status. A striking point in this table is that spending a positive amount and the 
average expenditure for those who spend is higher among children with overweight and 
normal weight BMI relative to obese and severely obese children. This could be due to 
unobserved socioeconomic status that is positively correlated with obesity and negatively 
correlated with access to medical care. 
4.5.3 Empirical Results 
 I intended to estimate the AIE using the five estimators discussed earlier. The GCF-
FIML estimator is burdensome and had convergence problems. I used the 2SGCF estimates 
as initial values for the one-step GCF-FIML estimator. 
4.5.3.1 Estimated AIE Across Different Approaches 
 Table 11 presents the estimated AIE of the five estimators discussed in sections 
4.3.1 and 4.4.3 (i.e., GCF-FIML, 2SGCF, 2SPS, 2SLS and 2SRI) and the FIML-EXOG, 
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GCF-FIML with “no 2PM is needed” null and OLS based AIE estimators.33 Panel A and 
B in table 11 report, respectively, the estimated AIE of a one-unit increase in BMI and of 
a hypothetical change that moves every youth BMI from an average normal to an average 
obese and severely obese. 
 The first and second rows in panel A of table 11 show that the GCF-FIML and 
2SGCF AIE estimates are almost identical. In both cases, a one unit rise in BMI across the 
entire youth population in the US leads to a $14.8 AIE on the total medical expenditure.  
The corresponding estimates based on the 2SPS, 2SRI and 2SLS approaches are $69.6, 
$117.41 and $45.88, respectively. The result I obtain for the 2SPS is close to that reported 
in Biener et al (2020) who find a $76 increase in total medical care spending.34 The GCF-
FIML AIE estimator that ignores the two-part structure of medical expenditure estimates a 
$23.17 increase in total medical expenditure to a one-unit rise in BMI. The FIML-EXOG 
AIE estimator which ignores endogeneity estimates a $1.64 AIE of a one-unit rise in BMI. 
Formal statistical tests, however, reject the “no 2PM is needed” and “X is exogenous” null 
hypotheses. Finally, I also estimate the AIE based on a linear model that ignores 
endogeneity of the X. The estimated OLS based AIE is a $3.08 increase in total medical 
expenditure. 
 
33 Each of these AIE are estimated based on deep parameter estimates from an underlying 
model. Table 10, for instance, shows the deep parameter estimates of the GCF-FIML 
model, which are used to compute the GCF-FIML based AIE.  
 
34 Note that Beiner et al (2020) specified a Generalized Linear Model with gamma variance 
structure and log link while the specification for the 2SPS approach in this chapter is a GG 
that subsumes the gamma distribution. Biener et al (2020) also used the biological linkage 
restricted use MEPS data to exclude children who live with stepmothers. 
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 Like the results from panel A discussed above, the different approaches lead to 
substantially different estimates for the AIE of a hypothetical change in BMI that moves 
every youth BMI from average normal to an average obese and severely obese.35 The GCF-
FIML and 2SGCF based AIE estimates reported in the first two rows on panel B show that 
such change in BMI would lead to an AIE of $143. The corresponding estimates based on 
the 2SPS, 2SRI and 2SLS approaches are $705.73, $1401.5, and $442.56, respectively.  On 
the other hand, the FIML-EXOG, GCF-FIML with one-part null and OLS estimates 
indicate that the total medical expenditure, on average, increases by $15.49, $224.35, and 
$29.01, respectively. 
4.5.3.2 Likelihood Ratio Test Results 
 I applied the likelihood ratio test discussed in section 4.3.2 to test whether 
parametric distinction between the EM and the IM is needed. The log-likelihoods based on 
the joint pdf under the “no 2PM is needed” null in (47) and the 2PM with NSD are 
L̂one-part= -150,638.61  and L̂GCF-FIML = -150,470.45 , respectively. Thus, the likelihood 
ratio test statistics is LR= ‒2 × [-150,638.61 + 150,470.45] = 336.32 , and 
P(χ(31)
2  > 336.32) = 0 implying that the 2PM is relevant to this empirical context. I also 
tested whether BMI is exogenous using a likelihood ratio test. The loglikelihood of the 
FIML model with no endogeneity and the GCF-FIML model where X is endogenous are 
L̂no endogeneity= -150,475.37 and L̂GCF-FIML = -150,470.45, respectively. The corresponding 
 
35 In the sample, the average BMI among obese and severely obese youth is 27.77 while 
the average BMI among normal weight youth is 18.35. 
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likelihood ratio test statistics is LR= ‒2 × [-150,475.37 + 150,40.45] = 9.84  and 
P(χ(2)
2  > 9.84) = 0.00006. Therefore, BMI is endogenous.  
4.6 Summary and Conclusion 
 In this chapter a regression-based approach is developed for causally interpretable 
AIE in the context of a generic FP2PM from the potential outcomes perspective. I consider 
the case where the IM component of the 2PM is continuous and the causal variable of 
interest is continuous and endogenous. By casting the AIE within the GPOF, I give 
unambiguous definition of endogeneity. I propose a new approach – a generalized control 
function (GCF) – to specify, identify and estimate causally interpretable AIE. Under a 
distributional assumption for the endogenous variable and regular IV conditions, the 
approach is shown to satisfy the CIND assumption that is difficult to hold in alternative 
approaches. Given a FP2PM for the outcome and a fully specified model for the 
endogenous variable, a FIML model and estimation method is developed for obtaining 
consistent estimates of the targeted effect parameter. A GG distribution is specified for the 
EM and IM components of the 2PM as well as for the endogenous variable. The proposed 
approach is suitable to conduct two important statistical tests: a test for a one-part null and 
a test for exogeneity of the causal variable. A simulation analysis is conducted to 
demonstrate the implementation of the GCF-FIML based AIE estimator and validate its 
consistency. A comparison of this estimator with conventional estimators shows that the 
proposed estimator performs better. Using data from the MEPS, I apply the approach to 
estimate the medical care spending effect of an increase in BMI by one-unit, and of moving 
every youth aged 11-17 from an average normal BMI level to an average obese and 
severely obese BMI. Following Biener et al (2020), I use mothers’ BMI as an instrumental 
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variable for children’s BMI. The GCF-FIML and the 2SGCF based AIE estimates are 
substantially smaller than those obtained using conventional estimators, which are 






















Summary, Discussion and Conclusions 
 In this dissertation, two regression-based approaches are developed for 
specification, identification, and estimation of causally interpretable (CI) average 
incremental effects (AIE). Both of the approaches are cast within the General Potential 
Outcomes Framework (GPOF) in which effect parameters (EPs) are specified based on 
relevant counterfactuals. The GPOF also makes clear the conditions under which such EPs 
can be identified and estimated using observed version of the data. The first approach is 
developed for specifying, identifying, and estimating causally CI AIE for a Partially 
Qualitative Outcome (PQO) – an outcome that manifests either as a value in the real line 
or a qualitative event. Casting a regression model for a PQO within the conventional GPOF 
is difficult because the only version of a PQO that would be amenable to conventional 
potential outcomes framework is the one that is conditioned on non-occurrence of the 
qualitative event. Such conditioning, however, would lead to bias due to bad control. By 
extending the GPOF, a new measure is proposed that maintains all the essential features of 
a PQO that is real-valued and is not subject to the bad control critique: a P-weighted 
conditional outcome. The second approach provides a Fully Parametric Two-Part Model 
(FP2PM) potential outcomes framework that allows a continuous causal variable to be 
endogenous. The two-part model (2PM) applies to cases in which the outcome of interest 
is nonnegative with large fraction of zeros. To accommodate endogeneity within the 
FP2PM, a generalized control function (GCF) model is specified in which a full 
information residual is recovered from a fully specified model for the endogenous variable, 
which in turn serve as a control function for the unobservable in the FP2PM. Given a 
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correct specification for the endogenous variable and under regular instrumental variables 
assumptions, the GCF approach is shown to satisfy the conditional independence 
assumption ‒ a key assumption for obtaining CI parameter ‒ that is difficult to hold in 
alternative approaches. The FP2PM with a distributional assumption for the endogenous 
variable gives a Full Information Maximum Likelihood (FIML) model which can be 
estimated via a FIML method. Using flexible distributional assumption, the consistency of 
the GCF-FIML based estimator for the specified targeted parameter is validated. Although 
a very flexible distributional assumption is used, to appease for any concern for 





















Table 1: Simulation Results of the Partially Qualitative Regression Model 
Parameter TRUE 
ML Estimates 
500* 1000 5000 25000 50000 100000 250000 
τQX
o  0.15 0.249 0.363 0.088 0.169 0.162 0.144 0.152 
τQV
o  -0.5 -0.5 -0.581 -0.486 -0.49 -0.502 -0.499 -0.5 
τQo
o  12 11.88 13.81 11.76 11.7 12.03 12 12.02 
τgX
o  -0.004 0.0053 -0.0103 -0.0031 -0.0045 -0.0047 -0.0038 -0.0038 
τgV
o  0.002 0.0001 0.0018 0.0006 0.0027 0.0021 0.0019 0.002 
τgo
o  8 8.032 8.01 8.03 7.98 8 8 8 
σo 0.175 0.183 0.176 0.177 0.177 0.177 0.175 0.175 
κo 0.95 0.839 0.78 0.908 0.963 0.921 0.961 0.949 
AIE 66.26 48.49 131.18 43.71 74.02 71.53 62.67 65.77 
APB  26.8% 97.9% 34% 11.7% 8% 5.4% 0.7% 
Subsample Size 
 
307 596 3011 15181 30217 60168 150067 










Table 2: Descriptive Statistics of the NSFG Data (Full Sample and By Live Birth Status) 
Variable Name 
Full sample  Live Birth  Non-live Birth 
Mean SD  Mean SD  Mean SD 
Outcome Variable         
Live birth 0.784 0.411  1 0    
Birth weight (grams)* 3283.57 613.48  3283.57 613.48    
Policy variable         
If smoker 0.136 0.343  0.125 0.331  0.175 0.38 
# cigarettes smoked per 
day 
1.12 3.979  0.908 3.42  1.89 5.477 
Control variables         
age 27.04 6.05  26.892 5.838  27.639 6.746 
Proportion that is         
Married 0.484 0.5  0.502 0.5  0.42 0.494 
Hispanic 0.264 0.441  0.278 0.448  0.214 0.41 
Non-Hispanic white 0.455 0.498  0.444 0.497  0.493 0.5 
Black 0.227 0.419  0.222 0.415  0.244 0.43 
Other race 0.053 0.224  0.055 0.228  0.049 0.215 
Less than High school 0.259 0.438  0.262 0.44  0.249 0.432 
High school complete 0.269 0.443  0.271 0.445  0.259 0.438 
Some college 0.265 0.441  0.259 0.438  0.287 0.453 
College 0.207 0.405  0.208 0.406  0.205 0.404 
N  15,658   12,274   3,384 
*number of observations for calculating the mean and standard deviation of birth weight in columns 2 and 3,  





Table 3: Descriptive Statistics of the NSFG Data (Full Sample and By Smoking Status) 
Variable Name 
Smoking Women  Nonsmoking Women 
Mean SD  Mean SD 
Outcome Variable      
Live birth 0.722 0.448  0.794 0.405 
Birth weight (grams)* 3151.15 622.406  3302.48 609.88 
Policy variable      
If smoker 1 0  0  
# cigarettes smoked per 
day 
8.249 7.604 
   
Control variables      
age 25.812 5.84  27.236 6.064 
Proportion that is      
Married 0.267 0.443  0.519 0.5 
Hispanic 0.1 0.3  0.29 0.454 
Non-Hispanic white 0.675 0.469  0.421 0.494 
Black 0.192 0.394  0.233 0.423 
Other race 0.033 0.178  0.057 0.231 
Less than High school 0.417 0.493  0.234 0.424 
High school complete 0.31 0.463  0.262 0.44 
Some college 0.231 0.422  0.269 0.444 
College 0.041 0.198  0.233 0.423 
N  2,126   13532   
*number of observations for Birth weight is calculated for a subsample that 












Table 4: Deep Parameter Estimates of the PQO Model 
 Probit estimates  GG estimates 









      




smoked per day 
      
Age at pregnancy -0.0204*** 0.0021  0.00147*** 0.0003 
      





      
Hispanic 0.188*** 0.0306  -0.00531 0.0039 
      
Black 0.0534* 0.0306  -0.0491*** 0.0041 
      
Other races 0.111** 0.053  -0.0210*** 0.0067 
      





      
Some college -0.0926*** 0.0372  0.00428 0.0041 
      
College -0.0419 0.0371  -0.00199 0.0048 
      
Constant 1.201*** 0.0583  2.013*** 0.0081 
Ancillary Parameters         
Sigma    0.163*** 0.001 
Kappa       0.934*** 0.0153 
N 15658   12274 








Table 5: Estimated AIE of Smoking Ban During Pregnancy 
Natility-weighted Bad Control 
Birth weight Birth weight 
AIE se AIE se 
32.68*** 3.178 11.35*** 0.036 




























1K 2.262 5.5% 2.250 4.9% 2.544 18.9% 2.712 26.4% 3.315 54.6% 2.860 33.3% 
5K 2.255 5.1% 2.258 5.3% 2.573 20.0% 2.711 26.4% 2.926 36.4% 2.763 28.8% 
15K 2.184 1.8% 2.185 1.9% 2.446 14.0% 2.968 38.4% 2.899 35.1% 2.662 24.1% 
25K 2.059 4.0% 2.057 4.1% 2.282 6.4% ** ** 2.674 24.7% 2.624 22.3% 
50K 2.159 0.6% 2.160 0.7% 2.425 13.1% ** ** 3.051 42.2% 2.704 26.1% 
100K 2.109 1.7% 2.109 1.7% 2.360 10.0% ** ** 2.800 30.5% 2.620 22.2% 
250K 2.141 0.2% 2.141 0.2% 2.366 10.3% 2.708 26.2% 2.859 33.3% 2.700 25.9% 
500K 2.133 0.6% 2.133 0.6% 2.361 10.1% 2.687 25.3% 2.786 29.9% 2.643 23.2% 
































1K 2.109 5.0% 2.107 4.9% 2.236 11.3% 1.595 20.6% 2.073 3.2% 2.349 16.9% 
5K 2.042 1.7% 2.043 1.7% 2.149 7.0% 1.693 15.7% 2.049 2.0% 2.172 8.1% 
15K 2.106 4.8% 2.106 4.8% 2.161 5.6% 1.765 12.1% 2.082 3.6% 2.267 12.8% 
25K 1.968 2.0% 1.968 2.0% 2.031 1.0% 1.545 23.1% 1.872 6.8% 2.120 5.5% 
50K 2.033 1.2% 2.033 1.2% 2.130 6.0% 1.681 16.3% 2.006 0.2% 2.184 8.7% 
100K 1.966 2.1% 1.966 2.1% 2.048 1.9% 1.649 17.9% 1.934 3.7% 2.097 4.4% 
250K 1.992 2.3% 1.992 2.3% 2.066 2.8% 1.656 17.6% 1.953 2.8% 2.139 6.5% 
500K 2.020 0.5% 2.020 0.5% 2.092 4.1% 1.654 17.9% 1.974 1.7% 2.150 7.0% 








Table 8: Descriptive Statistics for the MEPS Data (Full Sample and By Mother’s Obesity 
Status) 
 
 Full Sample        Mother BMI > 30  Mother BMI < 30 
Variable Name    
 Mean  Std. D Mean  Std. D Mean  Std. D 
Outcomes       
If Any Expenditure 0.681 0.466 0.693 0.461 0.674 0.469 
Total Medical 
Expenditure 993.556 3493.458 1013.307 3350.074 983.362 3565.313 
Policy Variable       
BMI 21.227 5.216 22.805 5.950 20.412 4.586 
Severely Obese 0.081 0.273 0.134 0.341 0.054 0.225 
Obese 0.144 0.351 0.195 0.396 0.118 0.322 
Overweight 0.183 0.387 0.209 0.407 0.169 0.375 
Normal 0.592 0.491 0.461 0.499 0.660 0.474 
Instrument       
Mom BMI 28.319 6.683 35.666 5.577 24.527 3.067 
Control Variables       
Age in Month 140.983 37.457 141.641 37.149 140.643 37.611 
Female 0.487 0.500 0.492 0.500 0.485 0.500 
Hispanic 0.381 0.486 0.439 0.496 0.351 0.477 
Black 0.250 0.433 0.257 0.437 0.247 0.431 
Medicaid Insurance 0.375 0.484 0.457 0.498 0.332 0.471 
Private Insurance 0.534 0.499 0.451 0.498 0.577 0.494 
Uninsured 0.065 0.246 0.064 0.244 0.065 0.247 
West 0.314 0.464 0.281 0.450 0.331 0.471 
Midwest 0.193 0.394 0.201 0.401 0.188 0.391 
south 0.358 0.479 0.408 0.491 0.332 0.471 
Mother is married 0.915 0.27854 0.897 0.304 0.925 0.264 
Mothers' Age group       
35-44 years 0.506 0.500 0.490 0.500 0.515 0.500 
45-54 years 0.223 0.416 0.203 0.402 0.233 0.423 
55-64 years 0.014 0.117 0.012 0.109 0.015 0.120 
Mothers' Education       
High School 0.198 0.398 0.226 0.418 0.183 0.387 
Some College 0.236 0.424 0.262 0.440 0.222 0.416 
BA Degree 0.145 0.352 0.095 0.293 0.171 0.376 
More than BA 0.115 0.319 0.072 0.259 0.138 0.344 
Mothers' Health       
Poor or fair  






Poor or fair  
(mental health) 0.053 0.224 0.072 0.258 0.044 0.204 
Activity Limitation 0.117 0.322 0.161 0.368 0.095 0.293 
Father is married 0.918 0.274 0.900 0.300 0.928 0.259 
Fathers' Age group       
35-44 years 0.473 0.499 0.490 0.500 0.465 0.499 
45-54 years 0.309 0.462 0.284 0.451 0.321 0.467 
55-64 years 0.052 0.223 0.044 0.204 0.057 0.232 
Fathers' Education       
High School 0.230 0.421 0.266 0.442 0.211 0.408 
Some College 0.192 0.394 0.194 0.395 0.191 0.393 
BA Degree 0.122 0.327 0.079 0.269 0.144 0.351 
More than BA 0.116 0.320 0.064 0.245 0.143 0.350 




















 Table 9: Descriptive Statistics for the MEPS Data (Full Sample and By Child’s 
Obesity Status) 
 
                                              Full Sample             Obese & above         Below Obese 
Variable Name    
 Mean  Std. D Mean  Std. D Mean  Std. D 
Outcomes       
If Any Expenditure 0.681 0.466 0.663 0.473 0.686 0.464 
Total Medical 
Expenditure 993.55 3493.45 869.83 3317.04 1029.47 3542.34 
Policy Variable       
BMI 21.227 5.216 27.771 5.674 19.327 3.118 
Severely Obese 0.081 0.273 0.360 0.480 0 0 
Obese 0.144 0.351 0.640 0.480 0 0 
Overweight 0.183 0.387 0 0 0.236 0.425 
Normal 0.592 0.491 0 0 0.764 0.425 
Instrument       
Mom BMI 28.319 6.683 30.847 7.421 27.586 6.265 
Control Variables       
Age in Month 140.98 37.46 129.59 37.10 144.29 36.91 
Female 0.487 0.500 0.413 0.493 0.509 0.500 
Hispanic 0.381 0.486 0.499 0.500 0.346 0.476 
Black 0.250 0.433 0.199 0.400 0.265 0.441 
Medicaid Insurance 0.375 0.484 0.493 0.500 0.340 0.474 
Private Insurance 0.534 0.499 0.410 0.492 0.571 0.495 
Uninsured 0.065 0.246 0.065 0.247 0.064 0.246 
West 0.314 0.464 0.297 0.457 0.319 0.466 
Midwest 0.193 0.394 0.178 0.383 0.197 0.398 
south 0.358 0.479 0.405 0.491 0.344 0.475 
Mother is married 0.915 0.279 0.873 0.333 0.927 0.259 
Mothers' Age group       
35-44 years 0.506 0.500 0.491 0.500 0.511 0.500 
45-54 years 0.223 0.416 0.167 0.373 0.239 0.426 
55-64 years 0.014 0.117 0.009 0.093 0.015 0.123 
Mothers' Education       
High School 0.198 0.398 0.228 0.419 0.189 0.392 
Some College 0.236 0.424 0.227 0.419 0.238 0.426 
BA Degree 0.145 0.352 0.096 0.294 0.159 0.366 
More than BA 0.115 0.319 0.074 0.262 0.127 0.333 
Mothers' Health       
Poor or fair  
(overall health) 0.108 0.310 0.146 0.353 0.097 0.296 







Activity Limitation 0.117 0.322 0.124 0.330 0.115 0.320 
Father is married 0.918 0.274 0.878 0.327 0.930 0.255 
Fathers' Age group       
35-44 years 0.473 0.499 0.504 0.500 0.464 0.499 
45-54 years 0.309 0.462 0.249 0.433 0.326 0.469 
55-64 years 0.052 0.223 0.035 0.184 0.057 0.233 
Fathers' Education       
High School 0.230 0.421 0.267 0.442 0.219 0.413 
Some College 0.192 0.394 0.171 0.377 0.198 0.398 
BA Degree 0.122 0.327 0.070 0.254 0.137 0.344 
More than BA 0.116 0.320 0.064 0.245 0.131 0.338 





















Table 10: Deep Parameter Estimates of the GCF-FIML Model 
 GG for X  EM  IM  
          
  Column (1) Column (1) Column (1) 
 δ̂ 
Std. 
Err.  τ̂EM 
Std. 
Err.  τ̂IM 
Std. 
Err.  
BMI    -0.005 0.0059  0.017 0.0057 *** 
Xu    0.124 0.0966  -0.271 0.0940 *** 
Mom BMI 0.004 0.0002 ***       
Medicaid 0.008 0.0046 * -0.310 0.0532 *** -0.034 0.0534  
Private -0.002 0.0046  -0.091 0.0531 * 0.308 0.0537 *** 
Uninsured 0.002 0.0065  0.698 0.0643 *** -0.375 0.0877 *** 
Female -0.011 0.0024 *** 0.022 0.0273  -0.064 0.027 *** 
Age (months) 0.002 0.0000 *** 0.002 0.0005 *** 0.001 0.0005 *** 
Hispanic 0.030 0.0030 *** -0.047 0.0346  -0.142 0.0355 *** 
Black -0.003 0.0031  -0.090 0.0372 ** 0.009 0.0354  
Midwest 0.000 0.0042  0.100 0.0531 * 0.016 0.0468  
South 0.009 0.0038 ** 0.235 0.0477 *** -0.068 0.0428  
West -0.003 0.0039  0.348 0.0482 *** -0.200 0.0443 *** 
Mom High School 0.001 0.0039  0.014 0.0424  -0.041 0.0451  
Mom Some College -0.004 0.0038  -0.156 0.0436 *** 0.162 0.0443 *** 
Mom BA -0.008 0.0046 * -0.267 0.0546 *** 0.208 0.0524 *** 
Mom BA plus -0.005 0.0048  -0.312 0.0570 *** 0.296 0.0540 *** 
Mom Age 35-44 -0.002 0.0035  -0.043 0.0402  0.085 0.0406 ** 
Mom Age 45-54 0.002 0.0048  -0.058 0.0546  0.100 0.0554 * 
Mom Age 55- 64 -0.011 0.0116  -0.168 0.1343  0.598 0.1331 *** 
Dad High School 0.000 0.0036  0.028 0.0410  0.040 0.0425  
Dad Some College -0.010 0.0039 * -0.071 0.0456  -0.055 0.0454  
Dad BA -0.015 0.0048 *** -0.111 0.0566 * 0.042 0.0541  
Dad BA plus -0.015 0.0047 *** -0.107 0.0554 * 0.055 0.0536  
Dad Married -0.018 0.0045 *** -0.138 0.0496 *** 0.003 0.0530  
Dad Age 35-44 0.011 0.0040 *** -0.083 0.0451 * -0.073 0.0459 * 
Dad Age 45-54 0.003 0.0048  0.047 0.0544  -0.063 0.0557  
Dad Age 55-64 0.001 0.0073  0.028 0.0826  -0.001 0.0840  
Mom Overall 
Health 0.004 0.0044  -0.164 0.0517 *** 0.104 0.0482 ** 
Mom Mental 
Health -0.006 0.0059  -0.160 0.0727 ** 0.410 0.0642 *** 
Mom Activity 
Limit -0.001 0.0039  -0.160 0.0472 *** 0.247 0.0431 *** 
Constant 2.491 0.0100 *** -0.887 0.1118 *** 5.338 0.1121 *** 
Ancillary 
Parameters                   





Kappa-X -1.051 0.0252 ***       
Sigma-Y       1.474 0.007 *** 
Kappa-Y       -0.095 0.0202 *** 
N 17,307 17,307 11,782 


























Table 11: Estimated AIEs of BMI and Obesity on Total Medical Care Cost 
 Panel A 
 ∆ = a 1unit increase in BMI 
Estimator AIE Asy-SE Asy-t-stat P-value 
GCF-FIML $14.87 1.77 8.42 0.000 
2SGCF $14.79 1.82 8.11 0.000 
2SPS $69.6 4.41 15.79 0.000 
2SRI $117.41 7.64 15.36 0.000 
2SLS $45.88 27.46 1.67 0.095 
FIML-EXOG $1.64 0.86 1.91 0.056 
GCF-FIML (ONE PART) $23.17 7.52 3.08 0.002 
OLS $3.08 6.85 0.45 0.653 
     
 Panel B 
 
∆  = average normal BMI  
‒ average of obese and severely obese BMI 
Estimator AIE Asy-SE Asy-t-stat P-value 
GCF-FIML $143.52 17.23 8.32 0.000 
2SGCF $142.74 17.78 8.02 0.000 
2SPS $705.73 45.43 15.53 0.000 
2SRI $1401.5 82.33 17.02 0.000 
2SLS $442.56 267.53 1.65 0.098 
FIML-EXOG $15.49 8.19 1.89 0.058 
GCF-FIML (ONE PART) $224.35 75 2.99 0.002 

























 **The first three rows are based on the entire population and the last three rows 













Variables** Observations Mean Std. Dev Min Max 
 Xo 250,000 1.75 1 0.018 3.482 
Vo 250,000 26.97 7.01 14.88 39.12 
Q 250,000 0.4 0.5 0 1 
Yo 150,067 2932.6 585.4 409.9 4908.5 
 Xo 150,067 1.73 0.99 0.018 3.482 






Simulation Evidence on the Arbitrariness of κEM 
 Here the objective is to establish the validity of an AIE estimator based on the 
density of the standard gamma distribution, where the value of κEM is fixed arbitrarily to 










o ); ν).  (47’) 
where β
X1





 are defined analogous to (47). I conducted the simulation 
following the steps outlined below. 
Step 1 – I picked the values for the parameters that are conjectured to constitute an 
admissible reduction. In particular, ζ
EM
= 2.5 , σEM= 1.5  and κEM= 2  and set 
ν = |κEM|
‒2
= 0.25.   
Step 2 – I generated X (not endogenous) and Xo (a two-dimensional vector including a 
constant term say Xo = [Xo
+     1]. X and Xo
+ are uniform random variables with means and 
variances E[X] = 1.5, E[Xo
+] = 1, Var[X] = 1 and Var[Xo
+] = 0.25. 




     β
o1






Step 4 – Generate (non-endogenous X) binary EM data {I(Y = 0)} based on (47’). The data 
is generated with a sample size n = 1,500,000.  
Step 5 – Set νfixed = |κEM|
‒2
 where κEM is the value used to generate the data.  Apply the 
maximum likelihood binary outcome estimator to the simulated data based on the 
following conditional pdf 




















(1 ‒ I(Y = 0))
  (47’a) 
 
 






; not with 
respect to νfixed = |κEM|
‒2
 which is held fixed. 
Step 6 – Estimate the AIE(1) for X as  













Step 7 – I set νfixed = |κEM|
‒2
 at a different value and repeat Steps 5 and 6. Note that the 
same large, simulated sample is used to estimate the parameters of (47’a) and the 








Table A2: Simulation Result for Arbitrariness of κEM 
κEM νfixed = |κEM|
‒2
 Estimated AIE 
0.1 100 0.0267732 
0.25 16 0.026765 
0.5 4 0.0267342 
1 1 0.0266065 
2 0.250 0.0261212 
3 0.111 0.0257261 
4 0.0625 0.0256069 
5 0.04 0.0255895 
7.5 0.01778 0.0255879 
10 0.01 0.0255879 
 
The simulation results implies that the estimated value of κEM  does not affect the 














Sampling Design for a FP2PM with GG EM, GG IM and GG Endogenous Variable: 
Lower Endogeneity and Nonlinearity 





   δXo    δcon] = [0.75     ‒0.5     ‒1] 
for the linear index coefficients. The means and variances of Xo  and W
+  are set to be 
E[X
o
] = 1, E[W+] = 1, Var[X
o
] = 0.45 and Var[W
+
] = 1.5. I also set values for the shape 
parameters as σX = 0.51 and κX = 0.25.  
 2) For generating the values at the EM, I set the values for the linear index 
coefficients, the shape parameters and the parametric threshold for (51) as follows 
 [β
X1
     β
u1
     β
o1





   β
cons1
] are the coefficients for Xo and the intercept, respectively.  
 σEM = 0.5    
 κEM = 1 
  ζ
EM
 = 0.5  
Note that σEM, κEM and ζEM are not identified. 
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u2
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o2
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cons2





 σIM  = 1.5    
 κIM =  1.5 
  ζ
IM
 = 10 
 4) For testing the consistency of the AIE based on the proposed approach, samples 
of increasing size are generated based on the above sampling design. In particular, the 
samples are generated with the following sizes. 
 n = 1,000    
 n = 5,000     
 n = 15,000         
 n = 25,000   
 n = 50,000   
 n = 100,000   
 n = 250,000   
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